MEGAVITAMIN THERAPY
THE AMERICAN PSYCHIATRIC ASSOCIATION TASK FORCE REPORT ON MEGAVITAMIN AND ORTHOMOLECULAR THERAPY IN PSYCHIATRY
Canadian Schizophrenia Foundation August 1976 MEGAVITAMIN THERAPY
This is the second report published by the Canadian Schizophrenia Foundation to give wider dissemination to its members and to members of similar organizations in the U S A of corrections to the findings of the American Psychiatric Association Task Force Report #7, Megavitamin and Orthomolecular Therapy in Psychiatry The findings, opinions, and conclusions of these reports do not necessarily represent the views of the officers, members of the board, or all members of the Foundation Each report does represent the thoughtful judgment and consensus of Dr A Hoffer and Dr H Osmond who prepared it, and it is considered a useful and substantive contribution to the ongoing analysis and evaluation of problems, programs, issues, and practices in a given area of concern: orthomolecular psychiatry A. Hoffer, M13., Ph.D,, F.A,O.P., F,R.S.C.(C) President Canadian Schizophrenia Foundation MEGAVITAMIN THERAPY
In Reply to the American Psychiatric Association Task Force Report on Megavitamins and Orthomolecular Psychiatry
A Hoffer, PhD ,MD, F AO P ,R C P(C)
H Osmond,MB,MRCP,FRCPsych
Canadian Schizophrenia Foundation 2135 Albert Street Regina, Saskatchewan S4P 2V1
ACKNOWLEDGEMENT
The authors gratefully acknowledge the assistance of the Academy of Orthomolecular Psychiatry which made publication of this book possible with a grant of $2,000 An Examination o
Summary
Addendum
Section I - Brief Abstract of Orthomolecular Treatment by Saskatchewan Group
Section II - Brief Abstract of Corroborative Reports
Section III - Pauling Paper
Section IV Letters to the Editor
Section V - Comments on B. J. Wyatt s Comment (1974) on L. Pauling s Report
Section VI - Comments on the Double-Blind (Placebo) Methodology
Section VII Efficacy and Toxicity
Section VIII Letters
Section IX References
Section X Reading List in Orthomolecular Psychiatry
Section XI - REAL Attempts to Corroborate with Failure to Confirm to Original Studies
Copyright 1976 by Dr. A. Hoffer and Dr. H. Osmond. Published by the Canadian Schizophrenia Foundation. 2135 Albert Street. Regina, Saskatchewan S4P 2V1. No part of this book may be reproduced by any mechanical, photographic. or electronic process or in the form of a phonographic recording, nor may it be stored in a retrieval system transmitted. or otherwise copied for public or private use without written permission of the authors We decided to answer the American studies might have been differently Psychiatric Association Task Force written However, having completed our Report on Megavitamins and Ortho- critical study of our critics we feel that it molecular Psychiatry with some reluc- has been worth the effort and hope that tance since this kind of controversy is our readers will agree tedious and not really productive—there As far as the Task Force members are are many other things to do connected concerned we would remind them of with the well-being of schizophrenic Bernard Shaw s aphorisms: "If you would patients which should have higher injure your neighbor—better not do it by priority than answering the criticisms of a halves " committee none of whose members Since the report was clearly intended appear to have had direct clinical charge to injure us it was doubly botched of a single schizophrenic patient treated because, according to the American by orthomolecular psychiatric therapy Psychiatric Association, it was supposed- However, colleagues have pointed out ly a fair inquiry and as such it was a to us that we had a special responsibility failure from the start The moment that for replying to these critics, and if we we doubted the impartiality of the failed to do so it would be assumed that chairman and committee members our default indicated that we accepted (presumably selected by him) it ceased to some or perhaps most of their criticisms be an unbiased inquiry The APA s duty Our reluctance as we shall note later on was to ask us whom we would consider has been much more on account of the to be unbiased among their 25,000 multitude of errors than upon the high members or so, or how undue bias, one quality of the criticisms There is much to way or another, could be assured against be gained from the observations and Their arbitrary assumption that they even strictures of an intelligent, fair knew best is far more serious than the critic. We are not so conceited or so errors of Lipton, Mosher, Ban, et al provincial as to deny that, especially That four-fifths of the committee came with the benefit of hindsight, experi- from two institutions and that the other ments might have been done differently member was a rival experimenter in- and papers discussing and describing our dicated ineptitude and insensitivity. an examination of the american psychiatric association task force report "megavitamins and orthomolecular therapy in psychiatry" american psychiatric association, 1973
The Task Force To attain their stated objectives, a lack This report begins by stating that " we of bias and prejudice was essential It shall examine carefully and critically the may surprise those who believe that the claims, the supporting evidence, the American Psychiatric Association would theoretical basis and the contrary never allow its name to be attached to a evidence in detail." It is wholly proper document which did not meet these for a professional association to study a criteria to learn that three years before new treatment in this way The report this report was published the chairman of ends with these words, "this review and that Task Force was conducting himself critique has carefully examined the in a manner which did not suggest literature produced by megavitamin pro- impartiality Indeed, his behavior in- ponents and by those who have attempt- dicated to many who heard him speak ed to replicate their basic and clinical that he had already made up his mind work " It concludes that in this regard and was not inclined to change it "the credibility of the megavitamin At a public meeting in California proponents is low " The value that one arranged by Mr Joe Desilva of Local 770 attaches to the Task Force conclusions in Los Angeles, Dr. Morris Lipton read a depends largely upon the intelligence, paper on the theoretical aspects of zeal, honesty, and detachment with megavitamin therapy and touched briefly which its members approached the on treatment At this time none of the objective which they had set for them- Ban-Lehmann studies had been reported selves In this paper, we shall examine and Wittenborn s work was still in the composition of the Task Force, the progress Nevertheless, Dr Lipton s con- nature of its report, and the manner in clusions, which he expressed then, which it set out to examine megavitamin closely resembled what was published and orthomolecular therapy in psy- later by the committee of which he was chiatry, chairman We are not the first to have questioned manner, and, finally, explain, reason, the propriety of using this report as a and argue with other members of the source of information Linus Pauling, committee. It is with this in mind that in 1974, wrote: "The APA Task Force democracies government committees Repoft, Megavitamin and Ortho- always include members of the major molecular Therapy in Psychiatry, dis- political parties One-party committees, cusses vitamins in a very limited way however admirable their members may (niacin only) and deals with only one of be, are always suspect If a minority of two aspects of the theory Its arguments members believe that a report is in- are in part faulty and its conclusions are correct or unfair they can then register an unjustified " j Hoffer, 1974, following a official dissenting view which is pub- long and detailed examination, com- lished with the majority opinion The mented: "It is a mistake to use it as a presence of members experienced with reference source in evaluating mega- the treatment under review means that vitamin therapy because it is a mine of those appearing before the committee misinformation " These remarks may know that they will be questioned by any disappoint those who had supposed that one - of its members This deters people the APA would provide a useful and from presenting mere hearsay evidence reliable document, but they are less or opinions which cannot be backed with unexpected when one studies both the personal experience composition of the committee and its Second: Proponents of opposing views modus operandi may be allowed to cross-examine each When a committee is formed to report other. This is a procedure which was on a controversial issue, one assumes eventually done in the prolonged and that the matter is important enough to controversial F D A vitamin hearings warrant a careful, scholarly, and held in Washington recently Dr Miles detached examination. The APA Robinson, M D , asked to be allowed to Council on Research and Development cross-examine some of the witnesses was correct in appointing a Task Force to appearing before the hearing examiner examine megavitamin therapy for this This right was at first denied him, but Dr was a matter of interest, concern, and Robinson took the matter to court The discussion among both psychiatrists and examiner was then rebuked and ordered the public However, the Council erred to re-open the hearings to allow the gravely in failing to instruct the sub- cross-examination. The United States committee, chaired by Dr M Lipton, Court believed that a public inquiry that not only must the committee be fair should make every effort to determine and objective, but they must also appear the truth and decided that cross- to be so examination, which had been denied A committee can appear to be fair earlier, would further this process Either even when they are not truly so by using of these approaches alone increases the two procedures either alone or together. chances of objectivity, but to have even First: It may include among its an appearance of fairness and so warrant members those who have had direct public and professional confidence, both personal experience with the new treat- should have been employed. ment These knowledgeable members of In fact, neither was used Consequent- the committee can examine the data, ly the committee appears to have been question witnesses in an intelligent biased, and as we shall show, this appearance is not misleading No pro- vision was made to ask any physician experienced in the use of megavitamin Lord Devlin. a former British Law Lord (roughly the therapy to appear before it, even though equivalent of a Supreme Court Justice in the U.S.A.), was quoted in the London Times, June 26, 1975, as there were plenty available and willing to saying in his Charley Lecture that "a judge s most so Yet it has been reported that i mportant qualities were impartiality and second. the do appearance of impartiality sessions were held in which members Of the committee consulted other psy- its Task Force There can be no question chiatrists and sought their views, even that the Association s highest officers though they had never published any knew that there were cogent objections data on megavitamin treatment to the subcommittee chairman whom An official or legal body which they had appointed They made no conducted its affairs in such a manner attempt to remedy this in the meantime, would be promptly discredited The long before the Task Force had made its APA s posture is the more questionable final report, Dr Lipton was circulating a since it has always been very strong for preview of it, a copy of which came into constitutional and personal freedom and our possession frequently advocates the humane and It is a poor augury when the chairman sensitive conduct of governmental and of an important Task Force appears to be social affairs Perhaps the APA has prejudiced, but it is worse still if several forgotten that charity begins at home other committee members should also be suspect Dr. Morris Upton, The Chairman In all committees the choice of Dr. Thomas Ban chairman is important and indeed It is our contention that for a number crucial As we have noticed Dr Lipton of reasons Dr Ban was prejudiced made an unfavorable impression on the against the megavitamins from the start orthomolecular psychiatrists and others and that both the content and tone of his whom he addressed in California. He told publication and his public statements the California audience that he had never reflect this prejudice. In 1966 Dr. Ban used megavitamin therapy and did not was offered a comparatively small grant treat schizophrenics Nevertheless, on of money by the Canadian Mental Health the strength of having received his Ph D. Association to settle the matter of at the same university where Elvehjem "Hoffer s megavitamin claims once and and Woolley discovered that nicotinic for all " There is no reason to suppose acid was the antipellagra vitamin, he that the Canadian Mental Health Assoc- launched into a poorly informed attack iation directorship was particularly keen on the megavitamin treatment and its for any positive affirmation of this work theoretical underpinning. Since he It happened that one of us (AH) was a seemed to be so antagonistic, dogmati- member of the CMHA Advisory cally self-assured and, in addition, Committee and was present when Dr. ignorant about the matter in which he Ban produced his final research protocol. was going to inquire, one of us (AH) At this meeting he outlined a simple requested the APA to remove him from experiment comparing nicotinic acid and the Task Force on vitamin therapy in tranquilizers against tranquilizers only. It psychiatry This request was rejected on was pointed out to him that he had not the grounds that the APA Council on included provisions for ECT in Phase II Research and Development would insure patients He gave assurances that this the objectivity of its subcommittee and would be done later on as his studies monitor its reports developed Another committee member Recently Leff (1975) confirmed our made the same point, but was reminded conclusion that Dr Lipton was the main of Dr Ban s pledge Dr: Ban also stated author of the report when he stated," I d that no reports would be released until warn people of megadoses for mega- the entire study was completed Neither periods says Dr. Lipton, who wrote the of these pledges was kept APA Task Force Report." Lipton has, Since Dr Ban is a member of the since 1970, been the chief crusader committee responsible for the Task against orthomolecular psychiatry. Force s report stating "the credibility of Since this was the APA s official the megavitamin proponents is low," his position, it must bear full responsibility own credibility is open to similar for the errors and misrepresentations of questioning. He is well known for his tranquilizer studies and has published (Siegler and Osmond, 1974) At a many of them Some years ago he meeting in Washington arranged by informed one of us (AH) that much of his NIMH (1973) in response to pressure income derived from grants from from the American Schizophrenia Assoc- companies and other sources interested iation, Dr Mosher stated forcibly that if in selling tranquilizers He was thus every psychiatrist in the U S A believed inherently likely to be caught in a that megavitamin therapy helped conflict of interest He may well, in all schizophrenic patients, he would not sincerity, feel himself to be wholly believe it. He was being consistent For if unbiased, but one has only to ask what he considers that schizophrenia is not an would have happened to many of his illness, it follows then that no chemo- grants had he found niacin to be more therapy, particularly nutrient therapy, effective than tranquilizers He would can possibly work While Dr Mosher s have faced a painful dilemma It was forthrightness may be admirable, he can unfair to expect him to view the hardly be considered unbiased for he has persistence of megavitamin claims with made his biases perfectly clear One anything but concern and suspicion Dr might, of course, wonder how the NIMH Ban s eagerness to disseminate his find- bureaucracy could possibly justify his ings long before his final report appeared appointment to the schizophrenia was shown by his lecturing professional section. It would be just as appropriate groups and attacking orthomolecular for a well-known Christian Scientist to psychiatry He cannot be considered a head up a cancer program disinterested party to the dispute and Since the APA Task Force was pub- quite apart from the effect this may have lished Dr Mosher presented a report on had on his researches, the propriety of Soteria House, a special home for his being a member of the Task Force is schizophrenic patients for the provision questionable In any official inquiry he of Laingian-type milieu therapy In this would have been obliged to declare his report he shows an interesting difference position in attitude toward research data arising Psychiatrists who are supposedly from his own research and toward all the experts on subconscious motivation data originating from orthomolecular apparently do not interest themselves in psychiatry Toward his own data he the conscious motivation of those they displays a friendly cheerful optimism would have evaluate a new treatment concluding that Soteria milieu shows According to Lionel Penrose, who has great promise, even though at the end of studied these matters, two members of a the study period there is not even one committee of five are quite sufficient to index of improvement in which his group bias it in their direction should they was better than the control group The choose to collude With Doctors Lipton Soteria group required 167 days in and Ban on the committee, the odds residence compared to 21 days residence against a fair and detached report were in a psychiatric ward by the control small; however, there was a third group, a difference of 800 percent. This member, Dr. Loren E Mosher. Mosher truthfully describes as being significantly larger There was no dif- Dr. Loren E. Mother ference in global psychopathology after Dr Mosher was the head of the Center one year between the two groups But in for Studies of Schizophrenia of NIMH spite of the fact that in every index of This choice was a curious one since he change there was no difference Mosher has frequently stated that it is his concludes there is a trend favoring their personal belief that schizophrenia is not approach The difference, so slight it a clinical entity and it is not a disease or a does not appear in any of the tests, is series of diseases: He is a disciple of the maximized in his sanguine report. Scotsman, Dr R D Laing, and prefers to In striking contrast Mosher as a view schizophrenia as a way of life member of the Task Force adopts an
4 entirely different stance. Here he finds to us to have been grossly biased against no amount of data, no matter how great the treatment they were supposedly the difference, is persuasive. Here he investigating with complete impartiality. minimizes the difference Had Mosher In Lionel Penrose s view, which we have remained a pure critic as he was as a Task already noted, this would make it almost Force member his position would have certain for the final outcome to reflect remained less assailable, but having the views of the majority. exposed himself to public scrutiny by The committee represented two in- publishing a report he has shown his stitutions: (a) the National Institute of undoubted bias against orthomolecular Mental Health which since 1967 has been therapy and toward milieu therapy This as antagonistic toward the megavitamin is consistent with his remark several years approach as it was against tranquilizers ago that he would not accept mega- in 1955—it had two representatives, Dr vitamin therapy as valid even if every J. Levine and Dr L R Mosher; (b) the psychiatrist in the U S A did North Carolina Department of Psychia- try, College of Medicine, with Dr M A. In April 1971 AH wrote to Chairman M. Lipton, Chairman of the Department and A Lipton requesting that he disqualify of this committee, and Dr F J. Kane, himself as chairman because of his un- one of his professors Dr Kane was co- doubted bias. He did not reply. June 8 author with Dr Lipton of the privately 1971 AH wrote to President R S. Garber, circulated attack on orthomolecular American Psychiatric Association, psychiatry in 1970 before the committee repeating this request These letters are completed its studies or published its reproduced in the appendix Since then report in 1973 It is unlikely Dr Kane the public activity of at least three could have differed significantly from his committee members, Ban, Lipton, and chief even had he wanted to do so. Mosher, have confirmed our suspicions The appearance of bias is so powerful that no prudent person or organization that even if there had been none the would have chosen them as unbiased committee was incapable of submitting investigators in an important public n objective and fair report issue. Recently Emanuel (1975) wrote; Dr R Wittenborn, Ph D., was a "Teachers and students alike delude consultant of the committee and pro- themselves as to the worth of what is bably one of its least biased sources. It is transmitted but because the teachers not certain, however, that NIMH was of often play a role in the subsequent career this opinion when he was given five of students and become prestigious hundred thousand dollars to conduct his centers attracting the most able, these study Several years earlier, we were told delusions become self-fulfilling pro- by a well-known U.S. psychiatrist from phecies In no branch of medicine is the midwest that he had been ap- there less to transmit than in my specialty proached by the NIMH to direct this —psychiatry—by supervision, correct- same study He agreed on condition that ness of approach and doctrinal conform- one of us (AH) was retained as a working ity to an extent sometimes more appro- consultant for the duration of the study priate to a theological seminary Pro- He was promptly dropped from further bably the best training for any psy- consideration Apparently Dr Witten- chiatrist and perhaps internist too would born did not make this demand; as a be a year or more in general practice psychologist he may have been less where exposure to a wide range of human aware of the high feelings generated suffering and human responses to it among psychiatrists by megavitamin would teach a sense of proportion." treatment. However, he was not a Emanuel s strictures against professors member of the committee and so cannot may just as aptly be applied against this be held responsible for its conclusions. committee It is not our opinion alone Of the five committee members, then, that committees can inhibit progress in three by their own words and deeds seem medicine Lasagna (1967) recently wrote, "Indeed, it is not impossible that a series shrug, the hardly expressed innuendo of of inaccurate opinions from a number of one or other of our brethren? Thus, we distinguished experts would snowball work not in the light of public opinion, into an overwhelming endorsement or but in the secrecy of the chamber condemnation of a drug "Jain (1975) in a serious discussion of ethics refers to the Did the Procedures Used Provide for a enormous power wielded by establish- Fair and Objective Examination of the ment committees He discusses the Data? relationship of physicians to physicians, but his views are just as applicable when The bureaucratically inclined some- one considers the relation of new to old ti mes hope that by proper procedures the ideas He lists four reasons why com- effects of personal peculiarities and mittees representing old ideas resist new shortcomings can be avoided These ideas These are: (1) human nature (i e , hopes are frequently disappointed. In interpersonal hostility); (2) territorial this case, however, inadequate pro- imperative (i e , the threat of the new cedures combined with a committee ideas against old, widely established three out of five of whose members were ideas); (3) financial factors; (4) the clearly prejudiced against megavitamins generation gap made an unbiased report most unlikely The resistance of well-established Because there was no orthomolecular ideas no matter how mistaken against psychiatrist on the committee and none new ones is probably the major reason was asked to attend its deliberations, for the committee bias Their tran- nobody checked to see whether the quilizer-only idea of treatment is coupled literature had been examined properly, firmly to establishment professors, summarized fairly, and presented intel- directors of research and administrators li gently The committee s actions suggest There may be a feeling that giving up the that they relied upon the inertia of their old ideas will mean losing their place in colleagues to avoid criticism of their the hierarchy of the establishment So far report They appear to have assumed that not a single professor of psychiatry has their task was to prevent the public and given public support to orthomolecular the profession from worrying itself psychiatry even though a substantial unduly about orthomolecular psychiatry. number have given it private support In other words, the end was to encourage Jain then lists the difficulties facing the reader to adopt Dr Mosher s avowed new physicians The same fate meets position, which as we have already noted new ideas We will repeat the difficulties was that even if every psychiatrist in the he lists, except that we are referring to United States believed in megavitamins, ideas "Doctors controlling the ethics he would still not do so The means by committees are usually from the which they set out to achieve this will be establishment and it is no use complain- examined in detail Unluckily, there are ing to them " "Most of the maneuvers by many errors in the Task Force Report the doctors in the establishment are done and we keep finding new ones, yet unless under the name of the university or these errors are exposed the casual reader hospital or a committee to which the unacquainted with the literature can doctor belongs The result is that on the easily be misled into supposing that a surface, decisions appear to be based on Report published with the approval of sound medical reasoning not on personal the American Psychiatric Association bias which can only be uncovered after must be accurate and truthful exhaustive legal investigations " He then It may seem unlikely that a responsible quotes Sir Clifford Allbutt, "Unfortunate- professional organization such as the ly, the same kind of medicine is played APA would give one of its sub- with the cards under the table in the committees such license and pay so little intimacies of medical counsels Who is attention to the composition of that there to note the significant glance, the committee, but at the time when these
6 matters came under the APA s scrutiny, the word "shift" is usually used as a Washington was heavily infected by the pejorative term implying that theory or Watergate atmosphere. Minority views practice is constantly changing so that were not respected; "dirty tricks" were an duplication of experiments and re- accepted necessity of political life; futation of theories is impossible This is authority, whether presidential or pro- not so In our original report (Hoffer et fessional, was looked upon as limitless It al., 1957) we listed a number of possible was assumed that the big battalions had mechanisms by which vitamin B3 could not only the right but also the duty to work These were: (1) Elimination of the trample upon those who disagreed with vitamin deficiency We did not think them, using any means available. Ortho- then nor do we think now that schizo- molecular psychiatry was a nuisance to phrenia is due to a vitamin deficiency both the APA and the NIMH, and some The concept of a vitamin dependency members of both these establishments had not been developed, but when it apparently believed that anything that came along it created the possibility that would damage it would be doing a public some schizophrenics might be vitamin service It should not strain credulity that B3 dependent (2) Cerebrovascular if the CIA or FBI can sometimes be effects (3) Mass action on cellular overzealous in the defence of what many metabolism (4) Placebo effect (5) conceive to be the public good, less Depletion of methyl groups (6) Restora- prestigious agencies should do likewise. tion of acetylcholine esterase activity. (7) The Title Inhibition of DPNase (now called The Task Force was appointed to study NADase) activity (8) Acceleration of vitamin therapy in psychiatry as the title destruction of a schizophrenic toxin (9) of the report suggests Instead, it Direct antagonism to a schizophrenic attempted to deal with the megadoses of toxin We, therefore, have put forward a vitamin B3 only, and entitled the report number of theoretical possibilities for erroneously "Megavitamin and Ortho- further inquiry molecular Therapy in Psychiatry "Ortho- As we gained more experience with our molecular therapy was not examined treatment, we improved it It would because the committee stated that they surely be unreasonable and unenter- knew of no way by which it could be prising to continue recommending an tested original pioneering effort and to use exactly the same dosage and exactly the The Report same substances decade after decade. If We have read the report carefully and the same rule were applied to tranquiliz- then compared it with the original ers, psychiatrists would still be using the sources When this was done, our early doses of chlorpromazine and reserpine impression that it was biased and hostile recommended in 1955 Treatments, if in tone was confirmed There are many they are any good, grow and evolve For errors and omissions, while its scholar- some reason the committee seemed to ship is of such low level that it cannot be expect us to stand with the original doses trusted In the following pages we will of the original vitamins as they were used show this by using a point by point in 1952, thus ignoring the entire his- examination of the examples of bias and torical development of the ortho- error and sometimes sheer muddlement, molecular treatment It must be a matter of opinion as to whether the committee s Introduction expectations were naive, perverse, or (1) On Page 5 the report claims that both we "shifted" our position (The reader (2) Hormones are generally not used should have a copy of the Task Force by orthomolecular therapists unless there Report #7 before him, read the whole is a definite indication such as hypothy- booklet, then reread each page as we roidism, diabetes, etc continue with our discussion ) In science (3) Vitamin B3 was never considered a
7 competitor against tranquilizers This is the answers to these problems will come one of the notions developed by the with future research " committee Our original double-blind Cinader (1975), an immunologist, is experiments began before tranquilizers well aware of the importance of in- became available. They were, therefore, cliviclual variation in disease and therapy. not included in the design of these In discussing controlled comparison experiments and were not used for these clinical trials he writes, "A treatment studies They were used in conjunction selected by clinical trial may be in- with the program for other patients and appropriate for some patients who are still so employed using the standard cannot be identified in advance Such indications We have been continually treatment failure is due to the heter- surprised by the number of psychiatrists ogeneity of the disease or of the response who advise their patients that we never of individuals to the disease or the use tranquilizers When pressure from treatment or is due to both factors A their patients is great, they have fre- better definition, that is, identification of quently placed them on inadequate low homogeneous disease entities, is an age- closes of vitamins and promptly dis- old objective of clinical research " continued the tranquilizers This has, on We were aware of these factors many occasion, caused relapse for which the years ago and always described as vitamins were blamed We have always carefully as possible (within space limit- made it clear that even with correct ations of medical journals) the kind of closes the response can be slow patients we had treated The committee (4) On Page 6 they correctly refer to ignores this surely not out of ignorance the orthomolecular view that the schizo- (5) Page 6—The committee continual- phrenias are a group of illnesses with ly quibbles about terms. There is different biochemical aberrations, but, certainly nothing orthomolecular about thereafter, they ignore this basic view I:CT or about foreign molecules such as and do not distinguish between acute tranquilizers, but there is no reason why and chronic patients In 1957, Hoffer et a name designed to direct attention to al concluded, "although many chronic correction of metabolic disorders by ambulatory schizophrenic persons have nutrient therapy should be dropped responded to nicotinic acid therapy, because these other non-orthomolecular similar results have not been obtained methods are helpful adjuncts with chronic schizophrenic persons in (6) Page 7—The committee accuses us mental hospitals This suggests that of making categorical statements without either the chronic process is different systematic documentation This is not from the acute process, or that it is more so Orthomolecular therapists have malignant " provided large quantities of data based "Lack of response of nicotinic acid upon double-blind, clinically controlled, indicates that doses have been in- follow-up, and other studies The only adequate or that the biochemistry and li mitation has been the modern style of physiology of schizophrenic persons medical journals to reject papers they differ in some hitherto unsuspected deem too long Hawkins statement was a manner. The differences may be due to summary of a vast experience Not one of irreparable enzymatic damage as a result the committee had ever personally of a long inhibitory process, irreparable treated schizophrenics using the full functional destruction of vital cerebral treatment They are in no position to be centers, the presence of biochemical critical. Even if Dr David Hawkins had mechanisms not reversible by nicotinic given them 2,000 case histories, would acid, or an inability of the patient in they have been any more receptive? chronic stages of the disease to as- By quoting our statement on pre- si milate nicotinic acid adequately or to vention out of context, they deny readers utilize nicotinic acid in the same way as an opportunity to see how this hy- the patient in the acute stages Perhaps pothesis was derived Before flour in the
8 U S. A was enriched with small false So far, no one has repeated the quantities of nicotinamide, it was original double-blind experiments These thought that pellagra could not be used acute and subacute cases with a influenced in so simple a manner. but combination of vitamin B3 and ECT in enrichment of flour nearly eradicated comparison to placebo and ECT None of pellagra, a vitamin B3 deficiency The the reports listed in the Task Force Report use of larger doses might prevent followed these procedures development of vitamin B3 dependency. However, their statements on Page 8, Since we have already seen this in "The latter claim is probably correct children of some schizophrenic parents because it is virtually impossible to our suggestion is hardly fanciful. The replicate studies in which each patient committee may not agree, but since they receives a highly individualized thera- have never used vitamin B3 in this way peutic program with from one to seven their criticism is founded on their vitamins in huge doses, plus hormones, personal opinion and nothing else special diets, other drugs and ECT, which (7) Page 7—While attacking our sug- are added or subtracted not on the basis gestions for prevention they make such of proven biochemical abnormalities but unnecessary errors as referring to the rather on the basis of the clinicians Huxley Institute for Biosocial Research as individual judgment as to the patient s the Huxley Society and to the Academy needs It is also impossible to replicate of Orthomolecular Psychiatry as the studies in which as many as five years of treatment may be needed before results Association of Orthomolecular Psy- " chiatrists There are many other similar begin to appear, are not correct either. examples of simple carelessness through- If this was their opinion one wonders why out this document which should make they continued to write a report It is readers wary Authors who cannot get possible to replicate far more comp- names, titles, and dates correct may be licated treatments than those which we even less reliable in more complex have described, and very few medical or matters surgical treatments are completely (8) Page 8—We have received a favor- stereotyped and without individual var- able press perhaps because we have been iation The studies must be published open and honest with reporters, but our and those who wish to replicate them discussion with writers did not occur must first examine what was in the until they sought us out and many years original work Where there is doubt, or if after publications in medical journals necessary details are lacking, the ethical We have never had the same access to investigator aiming at replication the media as the APA with its great approaches the original authors and resources and paid staff members seeks their advice and clarification This doing public relations So far the Task was not done, whether due to careless- Force Report has not been very warmly ness, incompetence, or lack of good will received This may be because many is a matter for the reader to decide science writers have done their own (10) Page 8—We have never claimed inquiries and have concluded, as we that vitamin B3 is the crucial variable It have, that this report is not worthy of an is one of several crucial variables As important subject which bears on the many of our studies show, ECT and other lives and well-being of thousands of chemotherapy can be crucial We cannot suffering people. be sure why the committee chose to (9) Page 8—(lines 16-19) When the imply that we claimed that B3 was the committee writes, "consequently when a crucial variable; perhaps they felt that serious scientific attempt is made to unwary readers, being persuaded of this, replicate the clinical experiments under would fail to notice that important the specific conditions for which the treatment components had been original claims were made, one finds that omitted. Whatever the committee s the conditions have changed," this is motives its members overlooked the fact
9 that if they condemned a useful treat- referred to a Sugargate coverup, pointing ment unfairly the losers would not be out that the data could equally well be their professional opponents (us and our interpreted as showing that insulin and colleagues), but tens, perhaps hundreds glycemia control are more dangerous of thousands of patients. What in other than placebo But the UGDP scientists circumstances might be considered nowhere discuss this finding In other clever debating tricks becomes less words, double blinds do not guarantee clever and more irresponsible here that the results of an experiment will be (11) Page 8—Whenever the com- objective or accurate mittee refers to the negative double- Restak (1975) attacks most double blind experiments its Report employs blinds from another approach supporting such flattering terms as "the rigorous Hoffer and Osmond s (1961, 1963) earlier double-blind studies with vitamin B3" views Restak wrote, "one thing funda- and "the careful attempts at replication mentally wrong is the design of the deal with the explicit procedures." If typical experiment using human sub- an experiment which uses chronic jects All too often such experiments are patients rather than acute or subacute set up in a manner that almost guaran- ones, which ignores ECT as we originally tees emotional distance and alienation used it, and which uses entirely different between the experimenter and his sub- evaluative procedures can be called a jects. It is not unusual for many careful attempt at replication, then there contemporary researchers to have no is little hope in psychiatric research The personal knowledge of the identity of the committee adopts the rule that every participants in their own experiments experiment purporting to be double blind which are carried out via intermediaries which yields negative results is by All- too often scientific objectivity is definition "careful, rigorous " They do distorted to include callousness and lack not, however, apply the same rule to the of concern for the human aspects of original experiments done under our research " direction in Saskatchewan because Several of the psychiatrists who were presumably they consider that we were clinically involved with the patients in so biased that even the sacred double Wittenborn s and Ban s experiments later blind was not to be trusted became orthomolecular psychiatrists We doubt whether this committee was They saw improvement not visible to the so ill-informed as not to know that for all directors of the study because the s the faith placed in them, double-blind directors saw only paper and numbers, studies can be badly designed and not patients. Their clinical observations executed so that false conclusions result. were more meaningful than the APA For example, the University Group conjectures Diabetes Program (UGDP) concluded (12) Page 1—It would seem to us that biguanides (Phenformin) increased that one doctor experienced with a new cardiovascular mortality in diabetics. treatment would be much more trust- This was an expensive controlled experi- worthy than 1,000 who had never used it ment, but recently Biron (1975) wrote, If the committee wishes to play the 4 "There were so many flaws and biases in numbers game, they might explain why ; the design and execution of this trial, over 1,000 psychiatrists had the temerity " that experts in experimental design who to diagnose Senator Goldwater without meticulously appraised the methodology ever having examined him. and the results believe that there are few On Pages 1 and 2 the committee 4 6 reasons to ascribe the higher death rate extracted phrases or sentences from the i to the oral drugs, but many reasons to original reports in such a way as to bring; attribute them to differences in the out the worst possible interpretation of numerous pertinent risk factors that were what was said The only way to prove not measured at time of entry into the hostile bias is to examine the papers; study " In a satirical letter Biron (1975a) which have been published, to abstract them briefly, and to highlight the (13) Page 3, 4th paragraph—The com- conclusions therein We have, therefore, mittee seems to be, or wants to appear, referred to a large number of original naive when discussing the role of reports as well as to the corroborative pharmaceutical companies in the popu- papers which have been published larizing of drugs At the present time These are discussed in an appendix so as drugs hardly ever become popular unless not to burden the reader unduly But there are forces which keep bringing these reports should, be examined in them to the attention of the medical and detail and compared with the com- lay public When a pharmaceutical mittee s interpretations and conclusions company has a use patent on a drug it is As will be seen, the committee review Ale to invest heavily in its advertising has been marred by errors of omission, of knowing that other companies are pre- distortion, by incorrect references to the vented from profiting from the original literature, by bias obtained by a careful company s efforts Advertising consists selection of the literature and of the data of spreads in medical journals, frequent presented in any one paper Thus, from visits from friendly, personable, well- about 26 original reports they were trained salesmen who leave samples and seemingly unaware of eight, but they had literature, and articles sponsored in access in the literature to 19 Out of medical journals Drugs which are not about 29 corroborative reports they patented are known in the pharmaceuti- should have known about 15, but cal jargon as "orphan drugs. " They are referred to three or less But they did owned by no one and therefore are not discuss any study which was negative no promoted by any particular companies matter how badly it had been done In The vitamins are orphan drugs This one case they were instrumental in means that there are no detail men, no having one such study published even massive skillful advertisements to keep though there had been no attempt by the the vitamins before physicians as thera- authors to publish until now It appeared peutic agents An example is the pro- in a free journal edited by one of the motion of atromid, a British drug used for committee and distributed by NIMH, towering cholesterol and triglycerides Washington Nicotinic acid, the orphan, is an even Because the committee ignored so better broad-spectrum hypolipidemic many reports favorable to orthomolecu- substance Nearly every physician knows lar therapy while paying attention to any about atromid which is constantly before negative report, however obscure, it physicians in their medical journals in becomes possible to give their bias a three- to four-page spreads There is no mathematical form by using a frequency advertising whatever for nicotinic acid, distribution and the null nypothesis This and very few physicians are aware of its shows: li pid-lowering properties Reports Reports The committee admits there is a grain Favorable Unfavorable of truth in our charge that orphan drugs are less impressive to psychiatrists than those that have been massively ad- vertised They doubt whether there is much to this: "If however they contained Chi so 10 00 n c 001 the full truth, psychiatry would indeed be NAD reports are not included since in a sorry state, gullible to the seduction NAD is neither nicotinic acid nor nicotin- of advertisement, pitiful in its naivete" amide Not every favorable report was and so on counted This shows that the betting odds that the committee surveyed the literature fairly is less than .001, or one in We have not counted any of the papers in Ortho- molecular Psychiatry edited by D R Hawkins and L. a thousand that such a bias occurred by Fouling (19731 since higher chi squares would be chance alone. meaningless
11 It is for our readers to judge whether able Thus, the resulting lack of com- the committee may not have been over- mercial sponsorship further clouded optimistic about psychiatrists capacity recognition of lithium s potential " to resist advertising If they are correct Parsons (1974), a pioneer in the then many drug companies are wasting a development of nicotinic acid as a 1 great deal of money buying up space in broad-spectrum hypolipidemic agent, in 4; the journal of American Psychiatric reply to a hypothetical question, "why is Association and the APA s many other niacin with its long and impressive record j: publications It is possible that these vast not used more widely by clinicians?" companies are so slipshod as not to know stated, "as a non-patentable drug it has the benefits they gain from advertising? not enjoyed the commercial promotion 4 Other psychiatrists are not quite as of other lipid-lowering drugs " Parsons naive as this committee for example, himself is employed by a pharmaceutical Samuel Gershon and Baron Shopsin house and is speaking from personal (1973) in their book on lithium write, knowledge on these matters "another important factor contributing to The committee winds up Section II by the delay in using lithium for psychiatric suggesting that megavitamin therapy has y purposes is undoubtedly that its ready little scientific support and that legiti- availability rendered it commercially mate empirical attempts at scientific p non-profitable; drug companies neither replication have failed There are two investigated nor promoted its use Rowell main classes of scientists: (a) those like of Laboratories, a small pharmaceutical Linus Pauling, Nolan D C Lewis, H house in Baudette, Minn , had the Kluver, Gyorgyi, and others who make foresight and the initiative to support the original contributions; (b) those who " necessary investigational work finally follow along and re-plough fields already leading to the commercial marketing of opened Of the committee members 1 : lithium in 1969 " So far no Baudette- none are in the first rank They may be I company has come forth for vitamins excellent representatives of then== and they still remain orphans However, psychiatric establishment, but are not i a large number of pharmaceutical noted for their scientific contributions companies, not listed among the giants, This may be why this entire APA report do provide the vitamin tablets necessary reads more like a polemic as one would I : for orthomolecular therapy find in Time Magazine, rather than like a 1 The same conclusion was reached by a learned discussion as might appear in4 report released by the National Institute Science. j• of Mental Health in 1970 (revised in The committee finally writes, "legiti- 1974) entitled "Lithium in the Treatment mate empirical attempts at scientific; - of Mood Disorders " This report is replication have failed " The term legit-= introduced by Bertram S Brown, imate is an unusual word in a scientific r: Director He obviously does not disagree document. Presumably, the committee;) with this as there is no disclaimer. considered all the positive studies illegiti- On Page 1: "In the United States, mate however, neither the first report in 1949 The statement that the empirical3 nor the impressive Danish work pub- attempts to replicate failed is untrue fora as we shall show none of the studies4i C lished in 1954 aroused any research i interest in lithium " extolled and praised by the committeef "This situation seems strange at first have made the slightest attempt too glance, for the discovery of the psycho- replicate active properties of lithium was of great (14) Page 5—The committee wrote ,E: significance " an alternative hypothesis proposed by"! On Page 2: "Lithium itself, moreover, Hoffer " They ignored Osmond and;( was of no interest to the drug companies Smythies in this reference perhaps: until quite recently, because it is a because they were then not aware that; natural product and therefore unpatent- Smythies had found evidence supporting"
12 the use of vitamin B3, Perhaps the intent those who sign them agree are untrue? was to dissociate Hoffer from Osmond Surely Lincoln s warning has not been and Smythies They then state that the wholly forgotten in Washington where oxidation of adrenalin to adrenochrome the difficulties involved in fooling all of was demonstrated long before we refer- the people all the time have been shown red to it, but neglect to point out that we up vividly in the last few years discovered the psychotomimetic pro- (16) Page 6, second paragraph—"In perties of adrenochrome Oddly enough, their first experiments, started in 1952, the original work was completed at the they compared, in a double-blind study, University of Saskatchewan under the patients given nicotinic acid and nicotin- first professor of biochemistry, Dr Roger amide at doses of 3.0 g per day for 30 Manning, University of Saskatchewan at days with other treatments available at Saskatoon, in 1935 that time. The major tranquilizers were (15) Page 6—The committee refers to not yet available. ECT and sedation were only one out of nine possible explana- given to all patients as needed, but tions we gave for the action of vitamin insulin shock and autonomic drugs were B 3, i e , the methylation ideas. This, as avoided Assessment of results during the we have already shown, is one of many hospitalization was by clinical evaluation possibilities. They then state "not only is of symptom intensity At the end of the there no evidence for adrenochrome for- 33 days the patients were discharged mation in vivo, but the psychotomimetic home or, rarely, to a mental hospital. properties of adrenochrome have also Follow-ups after discharge from the not been replicated " Both these state- hospital were by contact every three ments are demonstrably false; there is a months with patients and relatives to substantial body of evidence that adren- assess adjustment to the community, job ochrome is made in vivo and this has and family. The follow-ups were made by been summarized in detail in our book social workers who did not know the The Hallucinogens (Hoffer and Osmond, treatment given, and occasionally by 1967) This evidence may not satisfy the letters and questionnaires Follow-up committee, but since they did not refer varied from about a year to somewhat to our book, we must assume that they more than three years Re-admission to were ignorant of it and so are in no hospital was used as a criterion of failure position to judge of treatment The results showed only The last part of their statement is small degrees of improvement on the simply untrue Double-blind experiments vitamin over placebo during the hospital- in Prague confirmed the hallucinogenic ization, but a decreased relapse rate in properties of adrenochrome It is listed in the first four years in the nicotinic add NIMH-sponsored literature as an hall- group related to use of drug either in ucinogen and is so recognized by Ban hospital or upon follow-up " (56, APA Task Force Report Reference) We were hoping to find one of our who wrote "after a considerable dispute, papers abstracted correctly But this was however, the psychotomimetic pro- not to be In this paragraph the perties of adrenochrome were con- committee confused two quite different firmed " Yet here is Doctor Ban, a co- reports, the original double-blind report signer to a report which states that its of 30 cases, and a second follow-up study psychotomimetic properties have not on a larger group most of whom had not been confirmed Several years ago he been treated in the double-blind experi- and one of us (AH) debated before a ment. group of psychiatrists in Newfoundland. (17) Page 6—The committee writes, When AH quizzed him about this "During a period of five years a total of statement he admitted that adreno- 82 patients were studied, 43 of whom chrome s psychotomimetic properties received placebo and 39 of whom had been confirmed. What is the point of received nicotinic acid." They did not the APA publishing reports which even include the important fact that 21 of the placebo patients also received ECT and committee continues, "but little dif- 15 of the vitamin group received ECT ference in the relapse rate " This seems to us an attempt to neglect This is an astonishing distortion of ECT as an important variable Then they what we reported, equivalent to calling continue, "In this study, the nicotinic black, white. We pointed out that over acid group had significant improvement the 5½ years of follow-up (June 1953 to in the hospital " What they did not say December 1958) all patients from the was that 31 out of the 39 improved second double-blind controlled experi- compared to only 18 out of the 43 ment were given either 1 g of nicotinic placebo group We reported this was a acid or 1 g of placebo per day after highly significant difference They also discharge The two follow-up groups did not record that doctors not in the were randomized. We, therefore, had research group were allowed the option four groups: (a) placebo in hospital and of requesting the medication given to after discharge; (b) placebo in hospital their patients be decoded if they felt and 1 g of niacin after discharge; (c) there was insufficient progress This was niacin in hospital followed by placebo; requested 18 times from the placebo and finally, (d) niacin in hospital and group and once from the vitamin group after discharge We showed results as (chi sq = 19 p < 001) Then the follows:
Group Treatment Percent of group requiring No. of In After readmissions after dis- 5-year Hospital Discharge N charge, year after discharge Total cures
placebo placebo 20 placebo niacin 8 niacin placebo 29 niacin niacin 25
It is obvious that the best record was creasing merit of treatment was as achieved by the niacin-niacin group and follows: niacin-niacin.> placebo-niacin> the worst by the placebo-placebo group niacin-placebo > placebo-placebo There The other two groups were in between was, in fact, a very significant difference We also reported that out of 118 with those patients on niacin in and out ; patient-years in community on niacin of hospital doing much better. Three there were seven readmissions, while five-year cures out of 20 on placebo- = from 182 patient-years on placebo there placebo (15 percent) is surely different E were 60 readmissions (chi square=20, from 19 out of 62 or 30 percent in the p<0001) niacin groups What did the committee The 20 placebo-placebo group re- read? quired 16 readmissions totalling 9. 1 years Then they added, "The only patients ? while the 62 patients on niacin at one who had a significant improvement with time or another required 39 readmissions nicotinic acid continued after discharge; for a total of 11.2 years Had they from the hospital were seven acutely ill required the same number of days in females " hospital relative to the size of the group It seems more charitable to ascribe this) they would have required 28 2 years. statement to a deliberate attempt to b Finally, we concluded, based upon six confuse rather than to accuse the authors indices of improvement, : (1) condition in of being unable to read This is what AH community, (2) number readmitted, (3) wrote on page 54 of his book (1962): "A -r number of readmissions, (4) number total of 33 patients received nicotinic well, (5) number much improved, (6) acid after discharge Of the nineteen five-year cures, that the order of de- rated improved, only nine retained this!`l status, but out of fourteen rated un- only group which differs significantly i mproved on discharge, seven improved from all the other groups listed in Table This latter group, although small, is the 24 " This table showed the following:
Statusin community — Treatment in Discharge well and much community N evaluation improved
19 la) improved 14 Ibl not improved
other treatment 31 lal improved 18 lb) not improved
What this table showed then was that published studies, while ignoring a out of 14 patients discharged as un- number, and list four reports they had improved on 1 g of niacin per day, seven never read These were APA references became well or much improved after at #33, 36, 37, and 40 These were papers least one year treatment in the com- read at the Brunswick Hospital meeting, munity In contrast, out of 18 discharged but never published None of the as not improved not given niacin but committee members were present This is given other treatment, only one became an example of padding It is customary well or much improved On the other not to refer to unread papers unless this is hand, out of 19 discharged as improved noted in the text. and continued on 1 g of niacin, only nine (19) Page 8—The committee made the remained well or much improved while following criticisms of megavitamin out of 31 evaluated improved or dis- work: charged but not given niacin only 13 (1) Contamination of studies by frequent remained well or much improved. use of ECT We have always shown This shows that 1 g per day is enough to dearly that ECT was an essential com- produce improvement in some and not in ponent of treatment for Phase II patients others, which is not surprising It has It is odd to term an essential ingredient a always been clear there is an optimum contaminant The committee still treatment and follow-up dose. We find attempts to play down ECT, presumably the committee s capacity to distort our to further their contention that vitamin findings incomprehensible and are at a B3 is the crucial variable loss to account for it It appears to be a (2) A nonrandom or biased selection of deliberate attempt to mislead unwary the small numbers in our studies com- readers in the hope that they would not pared with the total population at risk. compare the report with the original For the first two double-blind studies source If this was the intention then it every patient admitted who was schizo- was doubly deplorable for apart from the phrenic was taken into the study, falsification it underestimates the provided that his therapist allowed this to curiosity and zeal of some members of happen This is the way most studies are the public It suggests an arrogant and done We do not know of any studies supercilious approach to both the profes- where a random selection of all ad- sion and the public missions has been used All that is (18) Page 7—The committee stated, required by classical double-blind "Positive claims for the efficacy of methodology is that the allocation of nicotinic acid have been made by other patients into the treatment groups is workers " They then list a number of randomized The committee has created some new rules to suit their fancy: The ••• The difference between niacin and other treatment size of the groups treated was adequate in the community was statistically significant. Chi sq = 3.7 If <0.051. to test the null hypothesis and was somewhat larger than sample sizes used use until 1957 By then our first by Ban and Lehmann If our work is experiment was completed and our questioned on this count the same second one nearly completed Since then criticism should be levelled at Ban and we have published many reports compar- Lehmann Ban (1972) is uncertain ing vitamin B3 as a treatment component whether 15 to 30 patients in any group against tranquilizers alone. can yield any conclusion at any accept- (8) The final attack is a repetition of able level of thoroughness. earlier mistakes The committee wrote (3) The lack of clearly specified initial "In the first one the patients received the diagnostic groups or systematic rating of drugs only in hospital, did not improve patients This is false The reader must significantly in hospital but had a read our original papers where we lessened tendency to relapse for four described in detail diagnostic criteria and years after discharge." The committee evaluative methods used manages to be confused about even (4) The failure to specify chronicity. This elementary reports We concluded that is false as any examination of our the vitamin B3 patients were better off published data shows than placebo patients on discharge, but (5) Nicotinic acid was never the only that at the end of one year they had treatment given We have repeatedly reached a one-year recovery rate twice as emphasized that vitamin B3 was one of high as the placebo group. This the the main treatments in any series. committee terms "a lessened tendency." However, we have seen hundreds of As usual they play down the positive and patients recover on vitamin B3 alone We emphasize the negative more like hostile are prepared to demonstrate these to any attorneys than scientific inquirers Then physician who wishes to see our patients they say, "In the second study the reverse and their clinical records So far over 50 is true: there was an improvement in the physicians have done so and are now hospital, but the subsequent relapse rate practicing orthomolecular therapy was the same." As we showed earlier the 2 (6)"The number of patients in the follow- second half of this statement is false The up sample were small." This is a committee then remarks, "These dif- misleading criticism How many 10-year fering results are hard to explain." follow-up studies have been reported Perhaps so; if one cannot read almost with tranquilizers? We have recently seen anything must be perplexing Both one Perhaps the committee will bring studies showed that patients on vitamin others to our attention "Treatment and B3 therapy improved in hospital and had comparison groups were not matched as a significant decrease in relapse rates.;; to pre-treatment prognosis " This is But the committee falsely concluded another after-the-fact suggestion which white is black. makes it look as if the committee was We do not find any inconsistencies in searching desperately for every possible the statements in the last paragraph on criticism of our work They were much Page 8 It is true a few patients recover less critical of the Wittenborn and the very quickly on vitamin B3 therapy, but r Ban and Lehmann double blinds which that most patients recover more slowly 1 were not double blind Had they found This is also true of tranquilizers. We do such errors in our work there would have not understand why this is considered an been no end to their comments To be inconsistency It is a general phenom-z fair, in the original protocol Ban termed enon of all therapeutic drugs But with his study "semi-blind," but he conven- orthomolecular therapy a large pro-), iently ignores this in this report portion of patients recover fully to` (7) The committee is critical because in become doctors, lawyers, professors, our original double-blind studies we did farmers, white collar workers, and so on not compare vitamin B3 against tran- We have yet to see one schizophrenic: quilizers We would have done so, but physician become normal on tranquilizer tranquilizers did not come into general therapy only . " `
16 (20) Page 9—The committee finds (during pregnancy) to babies There is another inconsistency between a report evidence that it can protect babies by Saarma and Vasar (Ref 46) and their against the harmful effects of other reference to O Reilly (Ref 47) They say substances " Saarma et al cited negative finds for The New World Dictionary, Second nicotinic acid in acute schizophrenia College Edition defines broadside as This is what Saarma said, but the follows: "(1) The entire side of a ship committee knew the O Reilly study was above the water line; (2) (a) all the guns on chronic patients only since they listed that can be fired from one side of a ship; the title of his paper accurately as (b) the simultaneous firing of these guns; "Nicotinic Acid Therapy and the Chronic (3) a vigorous or abusive attack in words Schizophrenic." (See Ref 47 ) It was also especially in a newspaper; (4) the broad so listed by Saarma and Vasar who surface of any large object; (5) (a) probably missed the word in their (originally) a large sheet of paper printed proofreading on one side as with a political message or (21) Page 9—In complaining about in 17th century England a popular ballad our original methodology the committee also broadsheet; (b) a large sheet of cited three examples The first one is paper printed on one or both sides as from Hoffer et al (1957) where they with advertising and often folded " extracted sentences from a paragraph: We have never mass circulated any "When the adjustment rating is not communication, but have as a policy available for a particular patient but his prepared printed information letters progress after discharge is adequately which are sent only to lay and profes- known, , an impressionistic score is sional people who have written to us for given, but the committee carefully information. Nowhere in the precise omitted the rest of the statement: "(for definition of broadside is there anything example, good adjustment or poor remotely resembling anything we have adjustment) These findings, however, done However, definition #3 fits closest are excluded from the mathematical of all the APA Task Force Report evaluation of progress," Surely this is a In our personal communications, most important statement to leave in, which these letters were, we did not refer but if the committee had done so they to literature references. For the com- would have removed one of their mittee to treat these private letters as if examples of questionable methodology they were documents published in a However, this evaluative method was medical journal is grossly unfair used for nine patients out of the 30 as We have been using niacin on several follows: (a) from the placebo group four thousand cases since 1952. A large had poor adjustments; (b) from the number of females have become preg- nicotinic acid group, two; (c) from the nant and had normal children while on nicotinamide group, two—both being niacin There has been not one infant then in mental hospital This exclusion of born to these patients with any con- a crucial qualifying sentence suggests genital defect that either deliberate falsification or massive subconscious bias was at work. The APA Research Committee should Safety, Side Effects, and Relative Lack of have been more diligent in monitoring its Toxicity of Nicotinic Acid and Nicotin- Task Force amide, A. Hoffer (19696) The second example of the committee In this paper, AH differentiated is an attack on Chinaglia (1965) and the between side effects which may he a third example is an attempt to smear us nuisance and toxic effects which are The committee writes, "Hoffer in a potentially harmful. Side effects include: broadside for public distribution pub- (1) Vasodilation of the anterior part of lished in 1965 says, It (nicotinic acid or the body with a sensation of heat and nicotinamide) does not cause any harm itching (2) Nausea occasionally followed by medically serious " vomiting. The committee writes, "Hoffer for (3) Rarely activation of peptic ulcer example, in his 1967 pamphlet (18) and (4) Rarely dry skin and very rarely in his 1971 paper (13) cites violent increased pigmentation of flexor sur- vasodilatation Here is what AH wrote, faces "Nicotinic acid produces a remarkable (5) Headaches vasodilatation " The committee manages They are not dangerous and are easily to transform remarkable into violent, controlled by lowering the dose or using evidence of bias which can hardly be lost other means. Possible toxic reactions of on students of psychopathology To nicotinic acid include liver toxicity which round off this example they omit a is rare, occurring about one-tenth of the description of how this flush recedes if frequency with which it appears with one continues to take niacin tranquilizers It may alter the sugar- In 1971 AH wrote, "It is still not tolerance curve and may cause insulin clear how many of the gastrointestinal requirements to go up or down It may effects are due to the vitamin and how increase uric acid blood levels, but has many to the vitamin filler " This is how not precipitated or aggravated gout. the committee summarized it, "The There have been no reports of toxic gastrointestinal symptoms are attributed effects on the embryo Female rabbits on to the inert filler used in preparation of nicotinic acid produced normal litters. the B3 tablets " In this section the A H referred to findings which showed committee continues to distort both form that vitamin B3 could protect embryos and substance of what we wrote, from toxic effects of other drugs. Sub- presumably secure in the belief that their stances which prevent vitamin B3 from psychiatrist readers will not refer to the being incorporated into NAD are terato- original publications So far events have gens such as 6 aminonicotinamide supported their belief However, since :FlI Nicotinic acid protects animals against they were entrusted by the APA to these compounds Mosher (1970) quoted make an honest and unbiased report these studies and had he found any others may now become curious to see a evidence whatever for any teratogenic how they carried out a duty to which effect he would have certainly produced they were pledged both to psychiatry and it He concluded, "at this time there is to the public This entire section on side t little evidence either positive or negative effects reads like one of the glib reports with regard to the possible teratogenic with which Parsons takes issue. Re- effects of nicotinic acid " As he was garding peptic ulcer Parsons wrote, "Although in 1960 I reported five patients unaware of the earlier report this is whom ulcers became active during understandable. He subsequently apolo- in gized for his neglect to properly report niacin therapy subsequent experience the literature. has failed to show any close correlation " In a recent review Parsons (1974) "I do not hesitate to prescribe niacin in a discussed the side effects of nicotinic hyperlipidemic patient with previous acid. He wrote, "Many clinicians are ulcer " unduly concerned about the cutaneous With respect to liver toxicity high- flushing which niacin produces, lighted by the committee, Parsons states, apparently not realizing that with large Some of the serum enzymes used to doses it subsides early in treatment Such assess hepatic function may be mildly to negative attitudes have probably been moderately elevated during therapy AA enhanced by glib review articles listing These changes are usually not pro- symptoms and biochemical changes gressive, often returning to normal while which occur during therapy, but failing treatment continues Light microscopy ;g to clarify which could be formidable " "It has frequently shown no abnormality in is also well to emphasize that the flush is at worst merely a nuisance which is not • • emphasis ours. not in the APA report
18 hepatic tissue even when enzyme levels subject who had also been taking LSD, have been considerably abnormal " hashish, and a curious form of psycho- "Similar liver enzyme changes occur with therapy The committee did not refer to a clofibrate therapy and appears to be letter of rebuttal, from Hoffer (1969) inherent in these drugs without signifying Here he wrote "This pharmacologically hepatic damage " Jaundice has been very naive report deserves little comment rare. except that it will certainly be quoted About hyperglycemia Parsons wrote, widely as evidence for niacin toxicity " the changes in carbohydrate tolerance We did not then realize that a committee have no clinical significance—unless the of the APA would be the first and only clinician incorrectly interprets them as group to prove this prediction correct evidence of diabetes " Discussing in- The committee s concluding paragraph creased uric acid levels Parsons con- on Page 44 of their report might be cluded, "Hyperuricemia occurs some- ascribed to a serious concern for the what less frequently but has not been welfare of patients But since every accompanied by gouty arthritis or renal known tranquilizer is many times more calculi " toxic, one has to weigh the risks of: (1) Parsons found pigmentary changes in Remaining chronically tranquilized and the skin not significant This he des- more or less ill for life This as many cribed as a localized velvety thickening authorities have indicated is occurring to and tanning of the skin especially in the an increasing number of patients with all axillae This change, which resembles the increasing risks of irreversible con- acanthosis nigricans, is of cosmetic ditions such as tardive dyskinesia and importance only It does not require that akinetic mutism (2) Recovering on the drug be discontinued Wittenborn et the orthomolecular approach while using al (1973) did not report any cases of vitamins the rest of one s life We acanthosis nigricans They wrote, "A believe that given such a choice and not substantial portion of the sample misled by prejudicial comments most developed a pigmented hyperkeratosis people would choose the latter The risks which in some cases bore a disturbing are small We have still to see a single superficial resemblance to acanthosis patient harmed by megavitamin therapy nigricans " They referred to a report by although we have seen those not Parsons But it is obvious that Parsons benefited During the same time we have who has been studying nicotinic acid seen numbers of permanently impaired since 1956 is not disturbed It is not the patients on tranquilizers The costs in tanning of the skin which is disturbing, terms of their lives and to the community but the unfamiliarity of Wittenborn and have not yet been computed, but they his colleagues with this phenomenon must be immense which excited and disturbed them There (22) Page 10, Attempts at Replication are no reports that nicotinic acid causes —The committee continues to insist that acanthosis nigricans The committee s vitamin B3 is the crucial variable for the statement was false when they wrote, entire orthomolecular program They use "and acanthosis nigricans have been this to justify their single-minded reported " From 853 patients treated with employment of vitamin B3 in their nicotinic acid for five years the Coronary experiments This sometimes seems to be Drug Project Research Group did not a deliberate attempt to confuse—one is report a single case They did not even unwilling to believe in such massive mention it as a side effect incompetence. Had Ban and Lehmann The committee referred to a case of seen fit (as they had originally agreed) to incipient psychosis produced by nico- repeat our original experiments using a tinic acid. They apparently read a letter combination of vitamin B3 and ECT, and to the editor by Heninger and Bowers had the results turned out negative, there (1968) who concluded that 1% g of is no doubt the committee would have nicotinic acid produced a psychosis in a dropped all reference to vitamin B3 as the crucial variable No matter how the studies not only for what Dr Wittenborn committee squirms about the issue, the reported, but the way this committee; fact still remains that no one has used his data It is not clear just what repeated the original two double-blind responsibility Wittenborn himself must) experiments Those who have employed bear for the committee s report since hef the entire orthomolecular technique was the consultant As with Ban the= have become enthusiastic users committee seems to be expert at mud-i i (23) Page 11—The list of negative ref- dling roles in a deplorable manner We erences on this page is interesting -will not concern ourselves with Witten-) Nowhere is there any reference in the born the consultant body of their report to our first study We will list the Wittenborn con where we showed that nicotinic acid clusions and then the committee s in- alone did not help chronic patients terpretation when they are different. (O Reilly, 1955) O Reilly was a colleague Wittenborn et al (1973) compared theI located at Saskatchewan Hospital, North effect of nicotinic acid, 3 g per day, Battleford At our request he ran a study plus tranquilizers against nicotinic acid) which was published in Diseases of the alone on an experimental group of 47 ill). Nervous System. This was the first on the average 4.8 years against a control published account of lack of response of group of 28 ill 3.0 years. They found: (1) chronics We have since then always 24 percent from the vitamin group were„ made this clear as is evident from the dropouts and uncooperative compared ; review of our papers given earlier in this to 37 percent of the control This did not report O Reilly (1955) is reference #47 in reach statistical significance, but sug- ; ±) the committee report Then they refer to gests a trend for more cooperation): Ashby et al., who confirmed our report, among the vitamin group (2) A slightly , and to Greenbaum who gave one-third larger proportion in the nicotinic acid= the active dose to schizophrenic child- group remained in hospital each month ? ren No information was given about the This difference was not statistically)) number who were cases of infantile significant. (3) There was no difference in autism the rate of readmission to hospital or inw The McGrath et al report discussed number of days spent in hospital. (4) 265 patients of whom 115 or 43 percent There was no significant difference in were ill five years or more, 91 (34 number of patients requiring tram ))) percent) were ill one to five years, and of quilizers, or in the amount of tranquilizer whom only 59 (23 percent) were ill one required (dose) At the end of the first; year or less Thus, only one-quarter were month, 87 percent of the vitamin group ;+ acute This is then a study of the effect of and 96 percent of the control group were- nicotinamide on chronic schizophrenics receiving tranquilizers, while at the ends There is no breakdown anywhere in the of 12 months these values were 77 paper between acute and chronics and percent and 89 percent At the end of response to treatment There is no two years they were identical at 75 r;; evidence in this report to support the percent (5) There was no significant;: committee s statement "no improvement difference between the two groups" was noticeable either after 30 days of clinically (6) Home and community, treatment or after one year in either the adjustment was more favorable in the; acute or chronic patients " McGrath et control group than in the vitamin group. 4? al also confirmed O Reilly (1955) (7) There were no cases of disturbedf The Wittenborn studies are reported in carbohydrate metabolism and gastro an interesting way And since Dr enteritis (8) A number of patients` Wittenborn is introduced "as an excep- developed a superficial pigmentation in tionally experienced researcher in the their skin area of drug effects on mental illness" it These findings were reported by the Yj is especially important to examine care- committee except for their first state-1r fully his "unusually comprehensive" ment (1) Subjects on niacin tended to
20 stay in the hospital longer, but the strong interpersonal commitments will statistical significance of this is un- respond well to niacin-supplemental certain What Wittenborn et al wrote therapy " This he proposed as a testable was that, "This difference continued hypothesis throughout the course of treatment, but The committee did not relish this did not meet the criterion for statistical second report and attempted to neutra- significance " There seems to be nothing lize and obscure these findings by writing uncertain about this last statement. in their conclusion, "the fact that he In a subsequent report (Wittenborn, finds no significant difference between 1973) first delivered in Washington and the total control group and the total later published Wittenborn (1974) re- vitamin group implies that a fraction of ported that he had examined a smaller his experimental population may have group of 24 patients selected on the basis had their progress impeded by the of certain predictor indices Half vitamin addition " There is no evidence received nicotinic acid Ten of the 12 whatever for this simplistic mathematical patients in the vitamin group had conclusion. Had there been any sub- outpatient adjustment scores of 0 60 or group identifiable in any way as a group higher at 24 months indicating a good made worse by vitamin B3, there can be outpatient adjustment score In the no doubt Wittenborn upon the urging of control group only five out of 12 the committee would have found it and achieved similar adjustment reported it Wittenbo n found "a high positive The committee referred to a possible predictor score was associated with a one-quarter of the group who did well on clinically important advantage for those vitamin B3 but neglected to refer to the patients whose treatment comprised 20 percent of the total group who were niacin supplementations " "For depres- made worse on tranquilizers alone Thus, sive retardation the percent of patients Wittenborn (1974) wrote, "one possible with substantial disorder at 24 months is explanation for the paradoxical per- approximately twice as great in the sistence of symptoms in these control selected control group as in the selected group patients with a good positive niacin supplementation group. For predictor score draws on observations schizophrenic excitement, the percent of that there are patients with a favorable patients with substantial disorder is more premorbid history who may possibly be than twice as great in the control group burdened by phenothiazine medication at 12 and 24 months as it is in the in their remission " He wondered if selected niacin supplementation group " niacin might be antitoxic to the pheno- Wittenborn (1973) stated, "There is a thiazines conceivable relationship between the But this is how the committee sum- fact that in the present sample patients marizes it: "although Wittenborn with a high predictive score responded considers his data to be consistent with tell to niacin and the fact that Hoffer the possibility that as many as one- and Osmond had claimed that niacin was quarter of his schizophrenic population more effective in relatively acute (those with good premorbid adjustment) patients than in chronic patients It is might be benefitted " We assume that probable that patients who, in the this figure is derived by multiplying present sample, had a high positive one-third (i e , the number of subjects predictor score would have been class- with good premorbid personality) by ified by Hoffer and Osmond as acute 10/12, i.e , the proportion who respond- schizophrenics. Perhaps in this way the ed to nicotinic acid plus phenothiazines. differential effect observed by them Note that the committee in criticizing could be in part explained " Wittenborn our work never talks about nicotinic acid further states, "those patients with and ECT in the same sentence, but here conditions diagnosed as schizophrenic they want to leave the suggestion it was who come to treatment with a history of the phenothiazine which should be r
emphasized. This may be how the of one-quarter based upon a mental committee arrives at the one-quarter hospital admission cohort, this is still 3. estimate. appreciable Having admitted that one- Wittenborn in his papers does not quarter might be benefited the com- make this sort of calculation In our mittee, by a form of convoluted reason- opinion Wittenborn had discovered un- ing which is very mysterious, states, "the usual and one might think unnecessary fact that he finds no significant dif- criteria for selecting Phase I patients The ference between the total control group proportion of Phase I patients, i e., acute and the total vitamin group implies a or less serious cases, varies with the fraction of his experimental population sample Thus, from a cohort of schizo- may have had their progress impeded by phrenics seen for the first time in the vitamin addition " One could just as outpatient clinics or by psychiatrists in well argue that had there been a simple private practice a much larger proportion placebo versus niacin study omitting are early, less serious, or Phase I. From a tranquilizers the results might have been cohort admitted to a mental hospital a even more significant in favor of vitamin Is much smaller proportion are Phase I Out B 3 of one practice in Saskatoon about 50 Wittenborn tried to save his study from = percent are early and AH is the first becoming too much in favor of niacin by 3 psychiatrist they have seen. The other suggesting that the 35 percent of his total half have been to one or more before and group were not really schizophrenic If : are more apt to be Phase II Since going this suggestion is accepted seriously, to a mental hospital very often means then the whole study must be in that there is no other facility willing or jeopardy For who would give a — able to take the patient they are more moment s consideration to an investiga- : chronic, have already failed to respond tion in which the chief scientist reports to treatment, and are generally more that one-third of the patients did not intractable It is, therefore, not surprising have the illness being studied? ; to find only one-third of the Wittenborn The committee totally ignored DeLiz s!3 group were Phase I But to be fair and (1973) charge that the Wittenborn study< objective the committee might have did not maintain its double-blind status 1_ abstracted Wittenborn s paper more Although Wittenborn maintained it was carefully Even so, there is no evidence double blind, he presented no evidence.; from the Wittenborn studies that the two that it had remained so There were no= ; main groups were suitably identical since questionnaires for either patient or staff: the placebo group were 1 8 years less to determine whether they thought they;;: . chronic (4 8 compared to 3 0) A were getting niacin or placebo DeLiz; substantial fraction of the poorer prog- stated that some patients were aware; nostic vitamin group could have res- they were on placebo and at least one ponded without any significant dif- purchased his own niacin This is not to ference appearing, and a substantial be construed as an attack on Wittenborn ` proportion of the better prognostic who is an able research worker, but ori placebo group might have responded had the methodology of theth e double-blind they been treated with nicotinic acid. technique It requires an al super ; Thus, the one-quarter estimate is so human effort to insure the double blind i crude as to be trivial not broken In other words, Wittenborn s study In the Wittenborn studies it would confirms our claims that a substantial have been impossible to insure it- fraction of schizophrenics, i e , Phase I, remained double blind because of the will respond to nicotinic acid without vasodilation He attempted to cover this: ECT. But we must emphasize that this is by starting the entire group on 50Q; seldom our recommendation today The milligram tablets to give them all the committee quibbles on the proportion in flush and then changing the lacebo Phase I Even if we accept their estimate group over to placebo But anyonep with
22 any experience with long-term niacin use this will be followed by the committee s knows that now and then throughout abstract treatment there will be random flushes, usually after the first dose in the Study No. 1 (58 in Task Force Biblio- morning We suspect that after a few graphy) Also published in Int. Zeit. Klin. months nearly every patient on niacin Pharm. Ther. and Tox., 54, 406-410, will know he has flushed and most of the 1972 group will know why In this study they treated 30 newly Furthermore, a number of patients admitted schizophrenics They do not who developed pigmentation had their describe them as acute or chronic, but as medication decoded and after a while newly admitted. This is an interesting were restarted on the niacin Thus, the term and suggests that the patients were double blind was not maintained through acute Anyone familiar with the Douglas no fault of the investigators (De Liz, Hospital in Montreal knows that newly 1975; Adams et al , 1975) admitted patients there include a large We now come to the Canadian Mental proportion of chronic cases, many of Health Association s studies begun with a whom had failed to respond to treatment grant given to Dr T Ban The reason the in a number of psychiatric wards in CMHA did this was that they became general hospitals The words newly disturbed by the claims that adding admitted have no meaning whatever and vitamin B3 to the treatment program the authors would have been more doubled the recovery rate They in- honest to have simply called them structed Dr Ban to disprove once and for admitted schizophrenics and to have all time our claims One of us (AH) that described their sample more carefully. year was on the Scientific Advisory Hoffer (1974) investigated these studies Council and was familiar with the back- carefully and wrote, "The patients were ground When Ban s initial design was divided into three groups, one group seen it was obvious he was prepared to receiving nicotinic acid, one group use only Phase I treatment, i e , no ECT nicotinamide, and the third group place- When this was pointed out to him he bos Neuroleptic tranquilizers were responded with the reassuring statement administered to all the groups on a that after their first researches were restricted scale It was intended to completed they would continue with investigate the patients for two years, but Phases II and III He also added there only six patients completed the entire would be no release of any information period Nevertheless, 25 patients spent until the entire program (Phases I and II) the first three months in hospital and at could be completed It now appears that the end of this period their clinical status he had no intention whatever of going was assessed by means of the Brief beyond Phase I treatment for all patients Psychiatric Rating Scale (BPRS) and, as events showed, he rushed into "It was found that there were statist- print very soon after the first study was ically significant improvements in the completed He was supported by CMHA total BPRS scores for all three groups who circulated his first report to every However, Table 3 of the research paper psychiatrist in Canada They have since shows that out of 15 BPRS items, the refused to correct the misinformation patients receiving nicotinic acid im- distributed therein claiming they cannot proved in 11 items and the patients be involved in any treatment contro- receiving nicotinamide improved in 12 versy Examination of Table 1 of the items, while the patients receiving committee report shows no evidence placebos improved in only six items whatever of any study repeating any of Thus, both the B3-treated groups scored our original double-blind studies improvements in approximately twice as (vitamin B3 and ECT as required) many items of the BPRS as the placebo- For each of their published studies we treated group The published paper also will abstract what the authors wrote and includes clinical assessments of the
23 patients at the end of the two-year study reached about the study depends on There were improvements in 10 out of 15 whether one takes the average number of items in both the nicotinic acid and the days spent in hospital as the critical nicotinamide-treated groups, but variable, or whether one takes the improvement in only six items in the number of symptoms of mental illness placebo-treated group Because 80 per- alleviated in the course of the treatment cent of the patients dropped out of the as the critical variable The latter is by far study before its completion, these results the more reliable are much less reliable than the ones "The Task Force Report has interpreted j obtained at the end of the three-month this study as demonstrating that (page period in hospital, when few patients had 15): The overall therapeutic efficacy dropped out However, the same general of nicotinic acid as the sole medication picture is obtained as at the end of the in newly admitted schizophrenic patients three-month period; that is, both the is not superior to the overall therapeutic ? nicotinic acid and the nicotinamide- efficacy of an inactive placebo treated groups improved in many more "This conclusion is based on the I3PRS items than did the placebo group " insignificant differences in average dura- The committee reports, however, "the tion of hospital stays The evidence overall therapeutic efficacy of nicotinic derived from actual psychiatric evalua- acid as the sole medication in newly tion of the patients, which showed a ! admitted schizophrenic patients is not definite superiority of both the groups_ superior to the overall therapeutic receiving B3 over the control group, is." efficacy of an inactive placebo In fact, not even mentioned " the majority of newly admitted schizo- phrenic patients—in a placebo control- CMHA Study No. 3 (No 53 in biblio- led two-year study with 30 patients— graphy) from J Hoffer: could not be sufficiently controlled with "The Task Force Report summary of high dosages—3,000 to 8,000 mg per the CMHA Study No 3 by Ramsay et day—of nicotinic acid administration al (53) also gives a false representation Further analysis of data revealed that of the actual findings On Page 15 the. during the two-year investigational Task Force Report states: period—regardless of whether the " From Study No 3: the overall; patients were kept on the project or therapeutic efficacy of nicotinic acid as:: not—the average number of days spent an adjuvant medication in newly in hospital was lowest in the placebo (211 admitted schizophrenic patients is in- clays) and highest in the nicotinamide- ferior to the overall therapeutic efficacy;; treated group (353 days) However, the of an inactive placebo number of days spent in hospital was " In fact, the addition of nicotinic; only slightly higher—214 days—in the acid, in the dosage of 3,000 mg per day,;` nicotinic acid than in the placebo- to the regular phenothiazine treatment—1 treated patients (58) " in a placebo-controlled six-months study" J Hoffer then properly concluded, with 30 patients—prolonged the duration; "The summary of this study given in the of hospital stay and increased the= Task Force Report doesn t mention these amount of neuroleptic medication ref results Instead, it points out that the quired in treatment average number of days in hospital The results of this study," J Hoffer during the two-year period was 211 days concluded, "do not show that patientsl in the placebo-treated group, 214 days in receiving nicotinic acid were made worse; the nicotinic acid-treated group, and 353 because of it The difference in thee; , clays in the nicotinamide-treated group, average duration of hospital stays was;; showing that the length of time spent in not significant The difference in the;. hospital was not significantly different average amounts of neuroleptic tran4" for the B3-treated groups compared to quilizers administered to the different` the control group The conclusion to be groups is of doubtful significance. The s i drugs were prescribed for more than half been something there The fact that only the duration of the study on the basis of half were able to do the HOD suggests short, outpatient interviews by resident these newly admitted patients were a psychiatrists (psychiatrists in training) very chronic group In Saskatchewan Even among experienced psychiatrists, only chronic patients incarcerated for the dosages of these drugs given to acute many years had this low a completion schizophrenics are highly variable The record on the HOD test Acute and dosage of a tranquilizer drug prescribed subacute cases never had more than a 5 for a psychotic patient is a very crude percent rate of not being able to and very indirect indication of his complete the HOD clinical status, and it can be influenced by a multitude of extraneous factors CMHA Study No. 4 from J Hoffer: "The direct and obvious method of "The final CMHA collaborative study assessing the condition of patients is by was conducted on 30 chronic schizo- observing them If B3 had worsened the phrenic patients In this study one group patients, it would be detectable by a of patients was treated with 3 g of worsening of their symptoms In fact, it nicotinic acid, one group with 3 g of was found that the B3-treated groups nicotinamide, and the third group was improved significantly The research given placebos The Task Force Report s paper states: summary of the results of the study is as Of the three, the nicotinamide- follows: treated groups showed statistically sign- From Study No. 4: the overall ificant therapeutic improvement on more therapeutic efficacy of nicotinic acid— individual items (9) of the BPRS than in the dosage of 3,000 mg per day—as an either the nicotinic acid or the placebo adjuvant medication in chronically groups; the latter two groups showed hospitalized schizophrenic patients is significant improvement on six and eight inferior to the overall therapeutic items respectively (53). -efficacy of an inactive placebo In fact, One may conclude that the B3- in a one-year placebo-controlled study treated groups in this study did not, in with 30 patients, the active treatment the overall assessment, improve more groups fared worse than the placebo than the control groups This has little group by all measures of assessment The relevance to orthomolecular therapy, in least improvement and the greatest which 133 would not be used alone and in amount of deterioration was seen in the such small dosages There is no evidence nicotinic acid group Moreover, it was that 133 worsened the condition of the shown that patients in the placebo group patients who were treated with it " required less increase in their concomi- Contrary to the findings of an in- tant phenothiazine medication than creased need for tranquilizers, Witten- patients in the two active treatment born found no significant difference in groups tranquilizer requirements, nor did he find "The actual published data shows that any difference in the number of days in every statement in this summary is false. hospital Thus, Wittenborn demolishes In the study, three methods of clinical two of Ban s main criteria of improve- evaluation were used: the Clinical Global ment Ramsay et al. did not report any I mpression Scale (CGI), the Nurses mean HOD scores, but did report mean Observation Scale for Inpatient Evalua- MMPI scores (only 11 out of 30 were able tion (NOSIE), and the Brief Psychiatric to complete MMPI) Half the group Rating Scale (BPRS) The patients were completed the HOD Had they given rated on these scales before the study HOD scores perhaps some differences began and after its conclusion, and the might have appeared Since as a rule they results are these: the changes in all three downgraded positive responses, one is evaluation scales before and after treat- left with the assumption there may have ment were insignificantly small for the patients in the two B3-treated groups and average dosages of the tranquilizers in the placebo group. There was no administered to the patients before and i mprovement and no deterioration in any after treatment were also insignificantly group small There was no evidence that the "It is clear that a treatment of 3 g of B3 patients in the placebo group required per day did not benefit these chronic less increase in their tranquilizer medica- patients This is a result to be expected tion than the B3-treated patients; the on the basis of the studies by Dr Hoffer statement to this effect in the Task Force and Dr Osmond and by Dr. O Reilly, Report is wrong " who had already reported that chronic In APA Bibliography #56 Ban and patients, like the ones in this study, do Lehmann also reported on 10 newly not respond to 3 g of B3 alone At the admitted patients (acute and subacute is same time, contrary to the claims in the given as a descriptive term, but no data is Task Force Report, there is absolutely no given on their chronicity) Three were on evidence that the administration of B3 nicotinic acid, three on nicotinamide, worsened the condition of the patients and four on placebo In this study the who received it It can easily be shown nicotinic acid group required 164 mg that the numerical variations in the tranquilizers/day and the placebo group clinical scales which were observed are 259 mg per day However, they down- small, random fluctuations which are grade this by promptly pointing out the due to the inexactness of the evaluation placebo group had fewer days in methods For example, on the CGI scale, hospital Neither of the indices has any the nicotinic acid-treated group went value in judging response to treatment from a pretreatment score of 4 1 down to There are too many clinical variables In 3 9 after treatment, an improvement of our own studies we never used duration 0 2 points The placebo group went from of first treatment admission as a 4.2 down to 3 7—an-improvement of 0.5 criterion, but we did use duration of points The nicotinamide group also readmission as a measure. Ban and ! )4 improved by 0.5 points (4 7 to 4 2) On Lehmann studiously avoided this latter the basis of this the Task Force Report statistic They can conclude, it would states that the nicotinic acid group be erroneous to amplify results of our had the least improvement and the clinical trials with other negative reports greatest amount of deterioration Yet the and to conclude that nicotinic acid has CGI scale in this experiment is inexact by no place in treatment of schizophrenic; a minimum of 0 6 points; any change less patients" This was one of their few: than that is equivalent to no change at correct statements, especially its first = all The nicotinic acid group s improve- part, based upon 10 patients in one study j ment by 0 2 points is not less than the and 30 in another Then they continue placebo and ni.cotinamide groups with the meaningless and trivial state- i mprovement of 0 5 points—all these ment, all one can say on the basis of changes are too small to have any these findings is that there is sufficient° significance evidence to suggest strongly that, "The Task Force Report states: the nicotinic acid or nicotinamide is not the; active treatment groups fared worse than treatment of choice for every schizo-;. the placebo group by all measures of phrenic patient under all possible; and without any further rl€€ assessment This is false for the nicotin- conditions :: amide group improved on the BPRS by consideration " Is there any drug used for 1 3 points (improving from a pretreat- any condition for which this statement,! merit 45 9 to 44 6 after treatment), while would be untrue? the placebo group deteriorated by 1 6 This statement was repeated by Dr J points (rising from 37.8 to 39 4). D Griffin, General Director, Canadian "As it happens, BPRS was imprecise by Mental Health Association (Progress at least 10 points, so these changes, too, Report 1) Since then and following his are not significant The differences in the retirement Mental Health Canada hasi
26 changed its position and no longer "And: officially wishes to be involved in the " On balance, these results suggest continuing controversy that the addition of pyridoxine may potentiate the actions of nicotinic acid. Study No. 7, from j Hoffer, page 26: Thus, pyridoxine seems to be a useful "Study No 7 of the CMHA studies adjunct to nicotinic acid therapy. " by Ananth, Ban, and Lehmann, 1973, is entitled Potentiation of Therapeutic Study No.12, from john Hoffer, pages 24 Effects of Nicotinic Acid by Pyridoxine in and 25: Chronic Schizophrenics It was intended "First, Study No 12, by Ananth, Ban, in this experiment to test the finding of Lehmann et al is entitled, Nicotinic orthomolecular psychiatrists that B3 and Acid in the Prevention and Treatment of 136 (pyridoxine), when combined, have Artificially Induced Psychopathology in an enhanced effect in the treatment of Schizophrenics (54) It consisted of a schizophrenia A 48-week double-blind study on chronic schizophrenics (Phase study was conducted in which one group Ill) in which half the patients were given of patients received nicotinic acid, one nicotinic acid in a dose of 3 g per day and group pyridoxine, and a third group half were given placebos, for two weeks. received a combination of nicotinic acid The neuroleptic tranquilizer therapy and pyridoxine. All the patients were which all the patients had been on was chronic schizophrenics The Task Force withdrawn As might be expected, the Report summarized the results of this patients receiving placebos deteriorated study as follows (page 15): significantly when the tranquil lizers were " From Study No 7: the overall withdrawn However, the patients therapeutic efficacy of combined receiving 3 g of B3 showed a marked administration of nicotinic acid and statistically significant improvement pyridoxine as an adjuvant medication in "All the patients were then given very chronically hospitalized schizophrenic large doses of methionine, 20 g per day, patients is inferior to the overall thera- along with their continued medication of peutic efficacy of the component drugs 3 g of B3 or placebos The hypothesis "This summary is a completely in- tested in this experiment was that accurate description of the actual find- methionine, which has been shown to ings in the study The results which were worsen the symptoms of schizophrenia, actually obtained and reported in the might exert this effect because it is a published research paper were the methyl group donor B3 , on the other following: hand, is a methyl group acceptor. It was " In this 48-week placebo-controlled hypothesized that the effectiveness of B3 study, the therapeutic effect of a in schizophrenia results from this combination of nicotinic acid and characteristic of the molecules of B3; pyridoxine was compared with that of that is, B3 might remove methyl groups treatment with either nicotinic acid or from some methylated compounds in the pyridoxine alone Of the three indices of body which could be causing the mental therapeutic effects, global improvement illness in psychopathology (BPRS and NOSIE) "After the administration of 20 g of scores was seen in all three groups; the methionine per day, all the patients number of days of hospitalization during showed a pronounced worsening of their the period of the clinical study was lower symptoms The Task Force Report has in both the nicotinic acid and the interpreted this as showing that nicotinic combined treatment group; and only in acid does not neutralize the methyl- the combined treatment group was the donating effect of methionine in daily average dosage of phenothiazine worsening schizophrenia This con- medication decreased. Thus, improve- clusion, however, is not justified, ment in all three indices was noted in the because there was a serious flaw jn the combined treatment group experiment The patients were given 20 g
27 of methionine per day, but only 3 g of not wish to continue the controversy. nicotinic acid Over 16 g of nicotinic acid Apparently the editorial board believed is required to accept the methyl groups they had already given too much space donated by 20 g of methionine. The to orthomolecular psychiatry. experiment was bound to fail "Sir: "This flaw was acknowledged in the "In a recent reply to my letter, Ban original published research report as well (1975) has retracted his earlier con- as in an official summary of it. The flaw is clusion Nicotinic acid failed to prevent not acknowledged or even mentioned in by prior administration or to relieve by `. the Task Force Report The only valid subsequent administration the methio- finding emer g ing from this study is that nine-tranylcypromine-induced exacerba- B3 not only forestalled the deterioration tion of psychopathology (Ananth et al., anticipated when tranquilizer medica- 1970, Canadian Psychiatric Association, tion was withdrawn, but it produced a 15, 15-20, 1970) He had in the body of ft significant improvement in the patients this paper recognized that 3 g of treated with it This finding is not nicotinic acid was totally inadequate to mentioned in the Task Force Report." counteract any methyl-depleting effect Methionine binds pyridoxine which is which could be ascribed to methionine. essential for the conversion of try- But having recognized this he should ptophan into coenzyme one, nicotin- have concluded that his experiment was amide adenine dinucleotide (NAD). The irrelevant and trivial and added nothing injurious effect of methionine is there- whatever one way or the other to any fore easily explainable It would be methylation hypothesis However, Ban almost a miracle if any quantity of finds it very hard to admit he has erred vitamin B3 could compensate for a and attacks the problem from another methionine-induced pyridoxine deficien- direction Although this recent idea of cy his does not appear anywhere in his w J. Hoffer therefore concluded (Page original paper, he now concludes that : 28): nicotinic acid had a negative therapeutic "In summary, three of the five CMHA effect on the two toxic drugs he had studies provide evidence to support the given his patients in large dosages findings of orthomolecular psychiatry. It is interesting to read again his The Task Force Report s description of original paper This I urge every reader to every study is biased and misleading It is do To help them follow the reasoning of ) remarkable that the authors of the report his earlier work I have subjected his make incorrect claims that B3 is worse paper to a critical scientific look than a placebo, putting the most In this paper, 20 chronic patients were ii negative possible interpretation to some divided into two groups of 10 each The: : equivocal research findings, while not 10 destined to receive nicotinic acid , even mentioning the research findings consisted of seven men and three that showed B3 was of clear definite women The control (placebo) group; benefit " consisted of three women and seven Recently, one of us (AH) criticized Ban men This immediately shows that his, (1975) for repeating his claim that randomizations had broken down and nicotinic acid did not protect patients that the experiment no longer met the against toxic doses of methionine. In his rules of double-blind methodology The reply he produced a new objection whole experiment should have been claiming that patients on a combination scrubbed, especially by a group so keen; of nicotinic acid plus methionine and the on methodology as Ban and his col -t amine oxidase inhibitor deteriorated leagues In effect the nicotinic acid; more The following letter was submitted group were male and the placebo group to the Journal of Psychosomatics, but female they did not want to publish it as they did In his introduction he ascribed to us-
28 incorrectly that we tested a hypothesis nicotinic acid) eight improved and two that nicotinamide would prevent excess deteriorated (P < 0 02) Out of the female methylation In fact, the hypothesis we group six deteriorated and two improved tested was that the addition of vitamin (There is however some confusion since B3 to the current treatment program these figures do not agree with Table 3 (then ECT and psychotherapy) would nor is it clear which scale is being used to improve the outcome, and it did We evaluate response) (P < 0 05) then described a large number of It is clear that in a group of mostly hypotheses to explain how it could work, male chronic schizophrenics who and the methylation idea was one of needed neuroleptic drugs all the time" them It was also one of our ideas (quotation from Ananth et al ) nicotinic (among a number of others) which led to acid not only prevented a relapse, but our first pilot trials in 1953 These produced an improvement They had not preceded our double-blind experiments reported for these patients on neuro- in 1953 to which Ban makes no leptics only The placebo group deter- reference He leads the unwary reader to iorated as one would expect believe we did not do double blinds We For the next two weeks the entire were the first psychiatrists ever to do group were placed on the amine oxidase them as is clear from our 1957 paper to inhibitor tranylcypromine, 30 mg per which Ban refers clay But there is nothing in the report to Then Ananth et al (1970) claim their indicate what happened to the patients experiment was double blind It was not For the next four weeks all the patients It is impossible to double blind any study were placed on 20 g of methionine per with nicotinic acid as any physician who clay has used it knows The initial dramatic But according to Ananth it was flush usually (but not always) recedes maintained for one week in six patients and is seldom troublesome, but nearly and for two weeks in another four That every patient on maintenance medica- is, half the group were dropped out tion even for many years will flush now before completing the four weeks This and then, especially in the morning with means (also not mentioned by Ananth) the first dose The flush is unmistakable that the same 10 were no longer on the by the flusher and anyone who sees it amine oxidase inhibitor Nowhere is Therefore, it cannot be double blind In there any indication which group, the our first experiment we used three nicotinic acid or placebo group, had the treatments, placebo, nicotinamide, and greatest number of dropouts. Therefore, nicotinic acid in conjunction with ECT if any meaningful evaluation is probably needed and with psychotherapy No one impossible in the unit knew that nicotinamide was The last period of four weeks the included and as it does not produce a original male nicotinic acid group were flush it was not detected This, then, was switched over to placebo while the a true double blind original placebo female group were l3an is well aware of the fact that you started on nicotinic acid cannot blind nicotinic acid because in In the female group (on nicotinic acid his first unpublished protocol he called it for the first time) the deterioration a semi-blind experiment No matter what started by placebo at the beginning of he called it, it was not blind, nor was any the study and intensified by toxic doses evidence published that it was It is of methionine was not reversed by strange that in studying the effect of nicotinic acid toxic quantities of methionine he did not Seven patients continued to deter- use a placebo comparison iorate and three improved From the After a two-week drug wash-out original male group (on nicotinic acid) period, the male group were placed on the original improvement caused by nicotinic acid and the female group on nicotinic acid and reversed by toxic placebo Out of the male group (on doses of methionine was not reversed by placebo These results are shown in the of methionine-homocysteine We have, following table taken from Ananth s own therefore, two possible ways by which results: methionine is toxic Yet Ban continues to use his early study as an argument worse no change better against vitamin B3 as a therapeutic agent a Patients originally on for schizophrenia. vitamin B3 and finally 6 1 3 The only reasonable conclusion from an placebo his entire paper is that it was poorly conceived, badly executed, poorly b Patients originally on placebo and finally on 7 0 3 reported, and faulty in its conclusions. vitamin 03 As I have said earlier, it is irrelevant and trivial to the orthomolecular controversy It seems to me that these groups are not and serves only those who refuse to read significantly different in terms of their the original papers pro and con and who response to placebo and nicotinic acid prefer to be led by authority and not by However, Ban writes, "Furthermore, it scholarship was noted that after discontinuation of The table on page 31 details the both tranylcypromine and methionine treatment, patients, and indices of administration there was deterioration change used by Ban and Lehmann and with nicotinic acid and some improve- those we used ment with placebo within a two-week Yet the committee can write, "The period " "It is this negative therapeutic negative findings in these carefully effect of nicotinic acid and not the lack controlled studies are clearly at variance of prevention of methionine-induced with results claimed by megavitamin exacerbations in schizophrenic patients proponents " It would be surprising that we keep on stressing, something indeed if the Ban-Lehmann studies could which Dr Hoffer systematically and have come to any other conclusion since )? consistently chooses to ignore " they used chronic patients mostly (even In other words, Ban bases his entire if newly admitted) without ECT for those case on the fact that with nicotinic acid for whom it was indicated and did no „ (given to the original female placebo follow-up studies Had we done our group), seven were made worse while in original studies the way Ban-Lehmann the other group only six were made worse did we would have undoubtedly come to and one showed no change their conclusions Is there any reason why this finding It should also be made clear that even should not be ignored? Had the one though they claim their studies were i,i patient changed from none to deteriora- double blind (Ananth et at , 1973), it is tion the results would have been identi- impossible to keep a patient on nicotinic cal acid unaware of the fact he flushes now Finally, Ban ignores the fact that and then and equally impossible to methionine binds with pyridoxine and prevent nurses or other staff from seeing.; produces a pyridoxine deficiency This the flush when it does occur They ( would be worse the longer patients realize they are on weak ground and , remained on the amino acid. Why would most often refer to placebo-controlled`` anyone expect vitamin B3 to compensate studies, thus lulling the unwary reader for a vitamin B6 deficiency induced by into believing these studies were double;: methionine? blind In our first double blind we used; Beaton et at (Biol. Psychiatry 10, nicotinamide as a hidden control, i e,; 45-52, 1975) found that methionine no one knew it was being used. In our;,: decreased REM sleep in rats and mice second study we did not use it, but told which was not reversed by nicotinamide everyone we were including it Thus ourM Their experiment suggests that meth- placebo and nicotinamide groups were: ionine does not increase methyl groups, true double blinds and the second was; but that the effect is due to a metabolite also by inference No attempt was madet;
30 newly admitted mostly chronic
Study C3—30 Study 14—30 Study f1—30
psychiatric ward in general hospital
previous treatment reported
treatment vitamin B3 plus vitamin B3 and ECT as indicated tranquilizers
double blind with no hidden control. therefore hidden control not double blind; original plan used term semi-blind
criteria for improvement nl number times re- ttl duration of first treatment hospitalization hospitalization
121 duration of re- 121 improvement in scales hospitalization
131 clinical improvement 131 amount of tranquil izer used Per day
It
in these studies to make them really obesity, and other toxic changes pro- double blind Finally, they presented no duced by tranquilizers we are delighted evidence that the code had not been we have only to deal with a few cases of broken by patients or staff, something nausea, flushing, and so on produced by surely that no modern double-blind vitamin B3 . methodologist would fail to do Claude Bernard emphasized in clinical In a recent report Ban and Lehmann experiments activities likely to harm and (1975) caution physicians against the use unlikely to help are by definition of these dangerous vitamins invoking the excluded In the Canadian experiments Hippocratic oath, primum non nocere of Lehmann and Ban this simple This is rather surprising when one reads condition was omitted and the omission their report #12 wherein they showed was so flagrant as to throw doubt on the that schizophrenic patients who were good sense, the fairness, and even the improved by nicotinic acid were then humanity of the experimenters This given a combination of a monoamine occurred most obviously in the experi- oxidase inhibitor plus a toxic dose of ment where chlorpromazine was with- methionine, 20 g per day, and so made drawn and the patients were placed on worse One wonders about the ethics of niacin At the end of the period of this workers who in the name of science phase of the investigation those on allow patients to be made worse while niacin had improved and those on trying to frighten physicians away from a placebo had become worse. The ethical vitamin considered safer than any tran- experimenter would then have given quilizer presently available. When we those on placebo niacin which was recall the cases of tardive dyskinesia, exactly what we did in our second niacin jaundice, incapacity to function, double-blind study Failure to do this was scientifically unsound for more infor- There are several means by which mation would have been gained this way, methionine could make patients worse: and morally inept What Lehmann and (1) by binding pyridoxine and producing Ban actually did was scientifically idiotic a deficiency of this vitamin, (2) by and morally reprehensible. It is incon- increasing homocystine ceivable that their mentally ill patients Thus, Beaton et al (1975) found that would have agreed to their second stage methionine produced behavioral and had they been in their right minds We do sleep cycle disturbances in rats and mice not believe their relatives would have which were antagonized by I-serine but agreed and no legal guardian could not by I-histidine or nicotinamide possibly have consented If the Canadian Apparently an increase in methyl groups _`: Mental Health Association associates was not a factor In their experiments j. itself with such an experiment then nicotinamide increased rapid eye move- `; public support should be withdrawn. ment sleep in contrast to methionine What happened was this The patients which decreased it who had been improved by the minimal We still believe the transmethylation (3 g) doses of niacin even though their idea is worth examining although it is tranquilizers had been withdrawn were likely to be only one possible factor It , given 20 g a day of methionine There was first proposed by Osmond and was ample evidence that this amount of Smythies (1952) Kety (1967) was in- methionine made many schizophrenics terested in this hypothesis, but it always `; worse and there was none that any had seemed to bother him that no trans- been benefited by it Under Bernard s methylation hypothesis can ignore rules it was a disallowed experiment vitamin B3 However, with a simple However, as Linus Pauling has stroke of the pen, Ban and Lehmann , emphasized even supposing one ignores (1975) have solved this problem for their;.; the ethics of the experiment and can colleague who is equally determined separate them from its scientific value never to allow additional adequate this was scientific nonsense The 3 g of clinical trials to be carried out by; niacin were substituting very successfully establishment centers Ban et al state, for the withdrawn chlorpromazine, but In 1967 Kety formulated the trans-f there was no reason to believe it could methylation hypothesis of schizophrenialja possibly cope with 20 g of methionine It by shifting the emphasis from the" says much for the ethical insensitivity psychotoxic compound produced byx and scientific obtuseness of the APA Task faulty transmethylation to the bio Force that this reprehensible experiment chemical process itself " By this they; seems to be well accepted by their hope to entrench Kety as the originator,; committee of the transmethylation hypothesis In their earlier reports Ban and However, to a biochemist, this statement!. Lehmann were convinced that the in- by Ban is meaningless The object of any ? ability of 3 g of niacin to reverse 20 g of biochemical reaction is the transforma-, methionine disproved a transmethylation tion of one molecule into another Only"; hypothesis and so removed a theoretical a molecule can be harmful, not the= rationale for the efficacy of vitamin B3. process of its formation They no longer follow this line of reasoning, but maintain that the niacin Pellagra, Schizophrenia, and the aggravated the toxicity of methionine Question of NAD compared to placebo An examination of The committee as usual finds that: ` their published data does not support speculations offered in 1957 for theme their conclusion There appears to be action of vitamin B3 are contradicted bya` little difference for methionine with other hypotheses considered 13 years tranylcypromine was toxic with or with- later In fact, no one knows why vitaminn out niacin [33 works and this will remain unknownf until research in this area is greatly attempts to replicate his findings have expanded resulted in a decrease of interest in the The argument that schizophrenia and nicotinamide adenine dinucleotide pellagra are not identical is spurious question " There is a wide overlap Many pellagrins The NAD problem was brought into a in southern mental hospitals were con- different light, however, by the system- fused with schizophrenia, and around atic studies of Pfeiffer and his collabora- the turn of the last century the dif- tors (1968) In combining the clinical ferential diagnosis included pellagra and with the electroencephalographic dementia praecox This is reviewed in a method, Pfeiffer and his group were able chapter in Orthomolecular Psychiatry to demonstrate that an enteric coated (1973) which the committee did not read NAD preparation does exhibit a thera- (at least they did not refer to it in their peutic action Pfeiffer et al s (1968) long polemic) See also Hoffer (1970) findings indicate that the claims about There is no doubt that pellagra produces the clinical effectiveness of NAD therapy a schizophrenic syndrome need to be further investigated with The committee then zeros in on our contemporary methods." nicotinamide adenine- dinucleotide Recently, Liebow and Rothman (1975) (NAD) studies First, they point out no reported that intact digestive enzymes studies have ever been published re- can be absorbed by the intestine and lating NAD blood levels to schizo- resecreted by the pancreas. They phrenia But they then fail to add that the specifically studied chymotrypsinogen, a relationship between blood NAD levels very large molecule, much larger than and pellagra is not good There are two NAD They further report that the main nucleotides: (1) the mononucleo- intestinal epithelium is permeable to a tides which are inactive as enzymes and variety of proteins and they list a number (2) the dinucleotide In pellagra even of references for this observation begin- though total nucleotides are in the ning in the year 1958 If such a large normal range, there is a significant molecule can pass through the intestinal increase in the mononucleotide fraction cell walls intact there is no reason why There are no studies showing how these NAD, a much smaller molecule, should substances are distributed in schizo- not pass through. And if it can pass phrenic red cells. Unpublished work by through into a cell there is every reason Philpott (1973) does show that schizo- to believe it can pass into other cells also phrenic erythrocytes in many patients are as needed The problem is to place NAD lower and that a vitamin B3 treatment far enough into the intestine to avoid the improvement coincided in time with enzymes of the stomach and the upper restoration of normal total nucleotide part of the small intestine This is why levels We would expect that schizo- special preparations must be used phrenic red cells contain too much Thirdly, they falsely state that the NAD mononucleotides and too little of the studies we published were thoroughly dinucleotide, NAD This has yet to be refuted by several groups We will now examined. show what we did and what these other Secondly, they state that NAD cannot investigators did penetrate into cells on a priori grounds Most scientists know that even the best a Our Studies priori reasons must give way before the We used a number of acute and facts Apparently, Ban was once aware of chronic schizophrenics, not chronic this since in 1970 he wrote, "In spite of patients only as the committee stated the challenging theoretical considera- Our exact words were, "In this study tions based on animal pharmacological NAD was given to a wide variety of studies and Hoffer s (1966) positive schizophrenic patients who had been ill therapeutic results, the unsuccessful from six months to 30 years " This study was done at University authors tried to test out NAD. The first Hospital, Department of Psychiatry, one was a study by Kline et al (1967) Saskatoon, Saskatchewan in 1966 One Kline used a number of chronic patients patient had been transferred from a who had been in the hospital for many mental hospital, Miss A N., the rest were years The committee conveniently either inpatients or outpatients None leaves the word chronic out even though had been chronically incarcerated in Kline had it in the title of his report. Kline mental hospitals even though they had also used his own preparation of NAD been ill for a long time which was impure and which could The NAD was a specially prepared hardly have survived passage through the enteric tablet in an oily medium The stomach Although the committee contents were designed not to be referred to HOD tests, Kline, in fact, did released for two—three hours after they not accept the conclusions of the HOD were swallowed We found that out of 18 which showed that the four patients on patients of whom six were much NAD had marked decreases in HOD improved and two improved before paranoid, perception, and total scores receiving NAD, 11 became well in a few while four patients on placebo showed weeks (some in a few days), three much no decrease in HOD scores Pfeiffer improved, and four improved When we found that Kline s preparation showed ran out of supplies of NAD within a few very slight activity on the quantitative weeks all the patients reverted to their EEG compared to our preparation earlier state Miss A N , as we reported, Gallant et al used the same NAD, but as was remarkably improved and this was he stated used a group of chronically witnessed by the psychiatrist who had incarcerated patients The other three if known her best, Dr M. Herjanic As long studies are irrelevant since we did not use as she was on NAD she remained well I V NAD Thus, it is clear that so far no } When we ran out she relapsed There was one has used the same two factors as we =` never any improvement thereafter even did, i.e , (1) a good preparation of NAD, (2) a group of acute and chronic cases for a day until she died in the mental i hospital a few years later who had not been chronic inmates of i We thus used a specially prepared mental hospitals They were typical NAD on a variety of acute to chronic psychiatric ward patients commonly cases of whom only one had been a admitted to general hospitals in 1966 chronic mental hospital schizophrenic The differences in the studies are There were a few studies where the shown in the following table:
Hoffer and Osmond Kline Gallant
Preparation a special commercial his own preparation same as Holler preparation
Patients acute and chronic. not chronic mental chronic mental chronically incarcerated hospital patients hospital patients in mental hospitals
In our report (1966) in reply to Kline we sulated in a heavy enteric coat, Canadian}:. wrote, "Because NAD is hydrolyzed Patent #670, 909—1963 It was released; readily by phosphatases in the digestive two to three hours after being swallowed tract, NAD given orally probably will be Earlier studies by Enzomedic Labora Thiiii inactive unless it is prepared in a special had shown that this preparationr form that will carry it into the intestine, was active in many patients when: where this destruction is minimized In unprotected NAD was not active the research reported in Enzymology of "Since Enzymology of Hallucinogens i Hallucinogens the material was sus- was written, we have given 1 g doses, pended in a special vehicle and encap - dissolved in water or placed in ordinary}
34 capsules, to a schizophrenic patient who is of little relevance to the pragmatic had responded dramatically to the question, does vitamin 133 work. It is of original NAD; there was no clinical immense theoretical significance, but response Then she was given 1 g per day not of practical value in the megavitamin of the original NAD; once more she B 3 debate NAD is not nicotinic acid or responded and remained very much nicotinamicle even though many psy- improved for nearly six weeks when, chiatrists are not aware they are dif- there being no more NAD, she quickly ferent relapsed and is still ill "This difference may explain the The Diagnosis of Schizophrenia findings of Kline and co-workers who It is not unusual for psychiatrists to found no response in 10 chronic schizo- play the diagnostic game if this will save phrenics They used NAD placed in their own hypothesis This is a problem si mple enteric capsules; in addition, it we have encountered since we began our was 70 percent pure and produced research. In 1953 one of the patients vasodilation (flush) in several cases, admitted into our double-blind control- indicating that free nicotinic acid was led experiment was screened in the usual present However, on the HOD test, way His psychiatrist diagnosed him to be completed by eight of their total group of paranoid schizophrenic and this was in 20 (four on placebo, four on NAD), there agreement with the clinical director AH was no change in scores with placebo, as Director of Research also concurred but the HOD scores decreased as follows: After two weeks on medica- tion he was nearly well whereupon his psychiatrist maintained that since Paranoid scores 575 to 3 25 schizophrenics cannot recover so quickly Perception scores 14 to 1.75 Total scores 63 to40 he was not schizophrenic As a result he did not follow medication at home and soon relapsed to be admitted in an "It is not possible, therefore, to acutely paranoid psychotic state re- determine whether their lack of clinical quiring a series of ECT plus nicotinic response was due to a form of NAD that acid On decoding we found he had been did not survive passage in the gut, or on nicotinic acid He remained well for whether they used too little, or whether it 13 years with no medication, relapsed was due to the chronicity of their and required two further admissions after subjects All of our series of 17 were a near-fatal suicide attempt On vitamin chronic, but only one had been severely f33 he recovered in 1966 and has injured by many years of continuous remained well ever since. Time sub- hospital treatment " sequently removed all doubt about The committee apparently did not read diagnosis. this addendum Recently a recovered schizophrenic on Finally, the committee finds it interest- vitamin therapy applied to an eastern Ivy ing no additional studies have been League medical school He honestly reported This is due to the fact we have described his illness and recovery fully been unable to obtain any more NAD expecting he would not be accepted To The Kline report effectively killed any his surprise he was. The admitting interest that drug companies might have committee told him that since schizo- had and none have been willing to invest phrenics never recover he could not have large sums of money in any further been schizophrenic This is the game—if studies If and when we obtain more you recover you obviously have not been supplies we will be the first to renew our schizophrenic The committee plays this studies We found it less interesting and game well Wittenborn had such a more annoying. careful screening system that a few However, whether or not NAD is patients believed to be schizophrenic finally established as a therapeutic agent were later rejected Later from this purified group he found 24 who as a Mahood (1963), but did not bother to group did respond well (half on placebo refer to a subsequent paper when thei ;f+ got worse on tranquilizers), but since errors and inconsistencies of this paper:; they did do well he assumes they could were discussed (Kelm et al , 1965) not be schizophrenic, following the As with so much of the committee s ; I committee rule, "if you recover you are report there was a rigorous avoidance of not schizophrenic " a searching analysis of all the HOD At the bottom of Page 24 the reports The fact that they were able tos committee repeats its false assertion that find only one negative report compared 4 CMHA studies were negative We will not to over one dozen positive reports repeat the counter claims which have indicates that there has been a rather= already been discussed. widespread use of this simple test The second paragraph of Page 25 is a The mauve factor work is reported in z totally misleading account of our work an equally biased way In our first papers This would have been obvious to anyone we reported that the presence of mauve= who has consistently and accurately read factor cut across all diagnostic groups,;.=! our reports Our criteria for diagnosis but the committee tries to leave the::„ have consistently remained that used by impression we claimed it as a diagnostic; most psychiatrists The HOD test was test invariably related to schizophrenia always an adjunct, never primary We Thus, it is not surprising that "other have not run any more double blinds workers (90) (O Reilly et al ) found the because having directed four of them mauve factor to appear across diagnostic; : there comes a point where further classes " O Reilly was our colleague and repetition is wasteful of time and money under our direction set up the laboratory" and does not convince One properly run to run mauve factor assays at his;., double blind which truly reproduced our hospital original double blinds by Ban and The committee s basic premise seems: Lehmann would have been more to be that none of the orthomolecular valuable than a dozen double blinds run research is of any value Therefore, they" by us We have never depended upon grasp at any research, no matter how; either HOD or mauve factor for any of badly done, which supports their our double-blind experiments In fact, and they call upon any theoretical idea?: our first two were completed before the no matter how wild which supports; mauve factor was discovered and the them This they have done with their HOD test developed brief examination of the mauve factor re-22 The committee then devotes Pages 25 search They ignored all the work; to 35 to discussing the HOD which is reported from Dr Carl Pfeiffer s laborat gratifying as it may arouse interest in our tory relating mauve factor (kryptopyr test (as it has already done), but is a role) to loss of pyridoxine and zinc complete waste of space since we did not None of the early workers with mauve= do HOD testing in any of our double- factor had suggested that it was an =i blind experiments endogenous hallucinogen because it had There are, however, a number of false not been tested The committee antici ` assertions about the HOD test such as the pated such a conclusion and on a priorBi statement it has never been studied for grounds concluded it was quite unlikely`, validity and reliability Each test kit it had this kind of activity They also, contains a manual which carefully based this on Sohler s findings, that it, describes these aspects of the test. Over sedated rabbits This is another example; 3,000 test kits have been sold, but of the committee s propensity to seizey apparently not to any member of the upon observations to bolster their own,, committee Had they inquired from us preconceived conclusions Recentlyr we would have advised them of the Walker (1975) concluded that "kryptop- presence of this data They referred to yrrole decreased EEG voltage, disrupted`=.. one negative report by Stewart and synchronization and induced abnormal;
36 spiking at a variety of cortical and schizophrenia these are nonetheless used subcortical sites Intermittent periods along with unspecified clinical criteria and low frequency hypersynchronous for the diagnosis of this illness, the EEG activity were consistently elicited by initiation of treatment and the assess- kryptopyrrole These waves bear a ment of improvement " Each reader will resemblance to the hypersynchronous have to determine the accuracy of these EEG pattern associated with hallucina- conflicting views by reading the litera- tory agents such as LSD-25 Marked ture. There is no substitute for reading behavioral alterations were observed the literature oneself following the initial injection including On Page 36 there is another typical ataxia, hyperventilation, locomotor misstatement Before modified ECT came depression, and catalepsy Kryptopyrrofe into general use we did use ECT as did causes major central nervous system everyone else, unmodified, but when it dysfunction and these findings are came into general use it became part of discussed in the context of a drug- the entire orthomolecular program induced model of psychoses " In his final paragraph Walker con- Quantitative Aspects cluded, "Hoffer and Osmond have The arguments in the last paragraph proposed that mauve factor now Page 40 and in the first paragraph Page 41 believed to be kryptopyrrole represents have been effectively answered by a metabolic anomaly that is associated in Pauling (1974) an etiological fashion with certain Their discussion on toxicity is bizarre psychiatric conditions, particularly to say the least. If the committee had schizophrenia They maintain that the found real evidence for toxicity they disappearance of this biochemical would have shouted it to high heaven anomaly is statistically associated with Had they treated the toxicity of any psychiatric improvement The results of commonly used tranquilizer in the same the present study strengthen the Hoffer- way they would be ethically bound to try Osmond hypothesis by demonstrating and force it off the market j Hoffer has that the introduction of kryptopyrrole adequately replied to their biased into the mammalian body is behaviorally reporting It is important to remember and electrophysiologically disruptive. that as codiscoverers in 1954 of the The abnormal behavioral reactions and hypolipidemic properties of nicotinic EEG patterns associated with kryptopyr- acid we have had more experience than role provided evidence that this com- any other physician with the potential pound has a serious detrimental effect on side effects and toxic reactions The first normal brain function " reviews of these aspects were ours, This report by Walker effectively appearing long before any member of the demolishes the committee s speculation committee was even aware of our that kryptopyrrole could not be an vitamin B3 work (see Hoffer, 1962) endogenous hallucinogen It has, so far, not been tested on humans, but in view Conclusions of Walker s report we doubt whether Our criticism of the committee and members of the committee will be their report is that: (1) The committee rushing out to try it out on themselves was in composition biased, failing to We trust that after digesting our ob- contain anyone who was familiar by jections to the methionine study they will personal experience with orthomolecular not be tempted to use it on unsuspecting therapy Not only was the composition patients incompatible with fairness, it could not This statement on Page 35 is a typical possibly even seem to be fair (2) The committee falsehood: "Although the procedure used by the committee failed evidence suggests that both mauve test to insure any objectivity or fairness for: as employed by Hoffer and the HOD test (i) they did not obtain any evidence from are not reliable for the diagnosis of anyone using orthomolecular therapy; (ii) they selectively examined the litera- amide when used as an adjunct to ture using the rule that any double-blind conventional therapies such as bar- study or allegedly double-blind study biturates and ECT as reported earlier by (even if it were not like the Witten- Hoffer may have a beneficial effect in the born and Ban studies) was evidence if it treatment of some patients suffering yielded negative results while conversely from acute early schizophrenia As far as no clinical study if positive was is known, no attempt has been made to scientific The four original double-blind duplicate these earlier studies (2) Mega- studies from Saskatchewan were suspect vitamin therapy has not been demon- since we did them, so were not evidence; strated to be generally efficacious in the (iii) the report is characterized by treatment of the vast majority of chronic falsehoods, direct and by inference, by schizophrenic patients. biased statements, by use of brief He concludes, "Orthomolecular psy- sentences taken out of context, by chiatrists should be invited to return to omissions which always favored the the forum of conventional psychiatry in committee s view; (iv) the report was order that they might be given audience written in order to bolster the com- Their articles should be submitted to mittee s negative conclusion conventional journals and should be received with the same enthusiasm and Unfortunately, the committee was cordiality as other submissions, provided correct in their assumption that most the general criteria of the journal are psychiatrists who read their report would met " accept it at face value and would not check their references The report has This is the first comment in any had a pernicious effect in dampening psychiatric journal where an attempt is interest in orthomolecular psychiatry made to be fair The editorial writer is not While this will not hurt any ortho- fully aware of the degree of misinforma- molecular psychiatrists it will condemn tion and bias in the committee s report, hundreds of thousands of patients to a but he has achieved adequate awareness lifetime of tranquilized chronicity to reject the committee s conclusions Fortunately, the number of ortho- Controversy is part of the history of molecular physicians is increasing medicine and is essential to it if medicine rapidly while the families of schizo- is to continue to advance There will phrenics become increasingly knowled- always be an establishment of ideas, geable about the illness and critical of some of which will eventually be proven the Establishment s posture wrong Thus, there will always be a Community psychiatry, which is controversy affecting various parts of essentially an expensive system for medicine However, worthwhile though delivering tranquilizers to chronic it is, there would be a lot less emotional patients in various shelters, is coming controversy if physicians followed the1 more and more into disfavor Psychia- basic rule of science, i e , follow the trists are sinking lower and lower in both same procedures and conditions when: public esteem and in the esteem of their attempting to corroborate If this rule; nonpsychiatric medical colleagues The were rigorously followed it would not, printing and distribution by APA of a matter whether the scientist was positive report so bigoted and biased as the Task or negative about the study But since{ Force Report can serve only to drive the this rule is seldom followed it does: psychiatric profession lower in public matter a good deal If the investigator, esteem has a negative bias toward the original In a recent editorial in the Canadian work he will conduct his studies in such a >D Psychiatric Association journal W T B. way as to maximize the negative con- (1975) after summarizing the pros and clusions and will then discontinue them.t cons of orthomolecular therapy con- There are many examples of this from the cluded: (1) Nicotinic acid or nicotin- reports of hostile anti-orthomolecular
38 psychiatrists. If they had run their studies were twice as high in the treated group more scientifically and longer they would Twenty-five percent of the treated have run the risk of seeing positive group had abnormal ECG while only 4 conclusions. A scientist with a positive percent of the control group showed bias may make the same error But in similar abnormalities. general the error of the negatively biased To dramatize his objections Dr Moss psychiatrist is much more serious In our posed a number of questions: opinion the failure to use a treatment 1 How can one evaluate treatment in which is beneficial is much more serious patients who do not have the disease? to patients than the error of concluding 2 How can one evaluate a drug if only that a nonactive drug is active For in the 46 percent of the group have hyper- latter case it will soon be shown that the glycemia? treatment is ineffective, especially if it 3 How can one evaluate a drug if has to compete with other more useful one-half should not have been given it? treatments Destroying a useful treat- 4 How can one evaluate a drug when ment by sloppy hostile research may the wrong doses are given? prevent its reintroduction for several Our objections to the negative thera- decades This would insure that large peutic trials upon which the committee numbers of patients will have lost their leaned so heavily are the same How can chance and will be condemned to a one evaluate the benefits of a drug (or of lifetime of unnecessary ill health a treatment program) when only a small Moss recently (1975) was severely proportion of the groups used were of the critical of the UGDP studies on tolbut- kind that could respond, when the amide The results from these double- treatment program was not followed, and blind controlled studies indicated that when idiosyncratic criteria for improve- tolbutamide was more hazardous than ment were used such as milligrams of placebo for diabetic patients But Moss is tranquilizers required and number of in total disagreement with this con- days in hospital during which treatment clusion writing, "No amount of statistical was started manipulation can compensate for the Another controversy, this time in- erroneous conclusions that are drawn volving the drug propranol, aroused Dr. from a study in which one-quarter did Lasagna to write, "Some (speaking of the not have the disease, three-quarters FDA advisory committee) appear to should not have been given the drug, the have gotten hung up on the concept of wrong dose was used and the treated the totally satisfactory paper! The only group had twice as much pre-existing totally satisfactory papers are fraudulent.. cardiovascular diseases " "The value of Every experiment has deficiencies and any therapeutic agent should be judged the problem is to decide whether the by the benefits that are obtained when it deficiencies are so great as to render the is used properly and not by the harm that experiment totally useless " results when it is used indiscriminately " The committee has demanded that our Moss pointed out that 23 8 percent of experiments must be totally satisfactory, the treated sample did not have diabetes but have for obvious reasons not according to standard criteria, 54 percent followed the same impossible rule for had fasting glucose levels under 130 mg their own favorite papers percent and did not require tolbutamide, 50 percent were more than 33 percent They are unaware of Dr Samuel overweight and should have been treated Johnson s rule, "nothing will ever be by a lower calorie diet Only 27 percent attempted if all possible objections must of the entire group were proper can- first be overcome " They demand of us didates for tolbutamide treatment The that our first double-blind experiments dose was constant whereas it is generally started in 1953 should have anticipated accepted it should be increased with all the newer findings and complications time, and base line cardiac risk factors discovered many years later The last controversy concerns DMSO, done at Munroe Wing, (2) a group of recently discussed at the third DMSO studies undertaken at the University conference, New York Academy of Hospital, (3) Dr O Reilly s study done at Sciences, 1974 (see annals New York the mental hospital at North Battleford, Academy of Sciences, 1975) On the (4) Dr Denson s study at North Battle- basis of flimsy evidence the FDA literally ford In addition to this, there is a great banned the use of DMSO Arthur L deal of clinical data from clinicians who Scherbel in his summary of the con- have used our approach for several tens ference stated, "This new policy resulted of thousands of patients This data is no in the abrupt discontinuation of clinical less important than the double-blind investigations of DMSO because of the studies on the grounds of sheer volume appearance of lens changes in certain alone The belief that double-blind " animals that were receiving high doses of studies alone are valuable is held by the DMSO This decision was made despite naive, whose knowledge of scientific the fact that no eye changes had been history and methodology is usually